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Bluetongue Vlrus (BTV) lS transmitted by arthropod 
vectors and causes bluetongue disease with serious economic 
loss in many regions of the world. The replication mechanism 
of bluetongue virus is still not clear. To have a better 
understanding regarding the viral replication, the function 
of each individual protein has to be identified. This study 
used molecular biology techniques to investigate the function 
of the inner core protein VP4. 
The M1 genes of United States bluetongue Vlrus 
serotypes-2, -10, -11, -13, and -17 were cloned and 
sequenced. The length of each of the five M1 genes is 1981 
nucleotides. The coding region of the M1 gene, which encodes 
the VP4 protein, possesses an open reading frame with an 
lV 
initiation codon (ATG) at nucleotides #9-11 and a stop codon 
(TAA) at nucleotides #1941-1943. This open reading frame 
encodes a protein of 644 amino acid residues with a predicted 
molecular weight of about 75 kDa. A potential leucine zipper 
motif was detected near the carboxyl terminus of the deduced 
VP4 amino acid sequence. The phylogenetic analysis of 
bluetongue viruses using the sequences of these five cognate 
M1 genes is consistent with the results of previous 
phylogenetic studies. Serotypes-10, -11, -13, and -17 are 
closely related and serotype-2 is the most distantly related 
among the five US BTV serotypes. 
Heterologously expressed bluetongue Vlrus VP4 protein 
was purified to near homogeneity. Six linear epitopes of 
VP4 were mapped at both termini and in the middle of the 
protein. By using enzyme-linked irnrnunosorbent assay and 
peptide competition assay, slx linear epitopes were found 
to be surface accessible. The VP4 protein was shown to be 
an oligomer by chemical cross-linking. VP4 protein was 
identified as a ssRNA-binding protein. The VP4 protein has 
binding activity towards both capped and non-capped ssRNA. 
RNA-binding activity was not specific to BTV ssRNA. A 
leucine-zipper motif of VP4 is not required for RNA-binding 
activity. One RNA-binding domain was mapped between amino 
acid residues #112-158 by a Northwestern assay and by 
deletion mutant analysis. Using sequence-specific 
synthetic peptides corresponding to VP4 in the arginine-
and lysine-rich regions, four potential ssRNA-binding 
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CHAPTER I 
LITERATURE REVIEW AND PROJECT OUTLINE 
INTRODUCTION 
Bluetongue viruses 
In the early twentieth century, Spreull (1905) 
described an animal disease that he believed to be found ln 
South Africa only. The infected sheep had high fever 
lasting for 5 to 7 days followed by conspicuous lesions 
that emerged in the mouth. The tongue was severely 
affected and became dark blue. Spreull proposed 
"bluetongue" as the name of this disease. This disease was 
later found in both domestic animals (sheep, goat, cattle, 
etc.) and in wild ruminants (blesbuck, elk, etc.) in most 
parts of the world. Bluetongue disease is an infectious, 
noncontagious, arthropod-borne viral disease, mostly of 
sheep (Erasmus, 1975). The disease can occur, clinically, 
as an acute, subacute, mild, or inapparent disease. In 
domestic sheep and white-tailed deer (Odocoileus 
virginianus), clinical signs occur rapidly within a short 
viral incubation. Goats, cattle, elk (Cervus elaphus 
canadensis), and other wild ruminants develop subacute or 
inapparent infections and are considered to have a longer 
viremia (Sohn and Yuill, 1991). The first sign of the 
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bluetongue disease is that the infected animal's body 
temperature rises with an average duration of 5 to 7 days, 
which may be transitory or continue for up to 14 days. In 
most of the cases, hyperemia and swelling of the buccal and 
nasal mucosa are observed at the time of temperature rise. 
The mouth area will have lesions resulting in excoriation, 
leaving bleeding, ulcerated lesions, which become infected 
and often necrotic. During this time the infected sheep 
develops lethargy and anorexla. Death may result from 
lesions of the smooth muscle of the esophagus and 
pharyngeal area and from heart failure (Marht and Osburn, 
1986b). Abortion, fetal death, and congenital 
malformations are also associated with bluetongue disease 
(Luedke et al., 1977; Osburn et al., 1971). The potential 
danger of this disease was intensively discussed ln an 
international symposium on bluetongue in 1974. Geering 
(1975) suggested that bluetongue disease was ln an 
epizootic situation and could cause a mortality rate up to 
70 % ln a highly susceptible sheep population. 
The bluetongue disease is caused by bluetongue Vlrus 
(BTV) classified in the Orbivirus genus of the family 
Reoviridae (Borden et al., 1971; Murphy et al., 1971). The 
Vlruses are transmitted among animals by insect vectors 
such as the biting midges of the species Culicoides (Wirth 
and Dyce, 1985) and distributed to most parts of the world. 
Orbivirus is designated for & group of viruses that are 
spread by arthropods and have similar morphological 
characteristics (Borden et al., 1971). The word "orbi" 
means circle or ring, referring to the round-shaped surface 
of this group of viruses. This group of viruses shares 
similar morphological and physicochemical features within 
the family Reoviridae, but there is not a common antigen to 
all v1ruses in the Orbivirus genus (Borden et al., 1971; 
Verwoerd et al., 1979). There are 14 serogroups 1n this 
genus distinguished by complement fixation tests (Borden et 
al., 1971; Karabatsos, 1985), including African horse 
sickness, bluetongue, changuinola, corriparta, epizootic 
hemorrhagic disease, equine encephalosis, eubenangee, 
lebombo, orungo, palyam, umatilla, wallal, warrego, and 
kemerovo. Based on neutralization tests, there are 24 
serotypes of BTV identified around the world, and only five 
serotypes (BTV-2, -10, -11, -13, and -17) are found in 
United States (US) (Barber, 1979; Mecham et al., 1986; Roy, 
1989). 
Bluetongue v1rus 1s an icosahedral-shaped particle 
consisting of a double-layered protein coat and has a 10-
segmented double-stranded RNA (dsRNA) genome (Verwoerd et 
al., 1972). The double-layer viral protein coat contains 
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two outer capsid proteins (VP2 and VP5) and five lnner core 
proteins (VP1, VP3, VP4, VP6, and VP7). Similar to 
rotavirus and reovirus, BTV has concentric protein shells 
and has no envelope. The negatively stained BTV virion has 
a fuzzy appearance and a diameter of about 70 nm (Verwoerd 
et al., 1972; Martin and Zweerink, 1972). It does not have 
any discernible structure, although virus-derived cores 
have icosahedral symmetry. Using cryoelectron micrographic 
image analyses, the outer capsid has revealed a well-
ordered morphology, and it is different from those of human 
rotavirus and reovirus (Prasad et al., 1988; Yeager et al., 
1990; Metcalf et al., 1991). From these images the 
proteins of the outer capsid have two shapes; one is 
globular and the other is sail-shaped (Hewat et al., 1992). 
The sail-shaped spikes are predicted to be the 
haemagglutinating protein VP2, which contains the Vlrus-
neutralizing epitope. The globular-shaped protein is more 
likely to be VP5. The structure of the inner core has been 
examined by cryoelectron microscopy to a resolution of 30A. 
The inner core has a diameter of 69 nrn, and it contains 260 
copies of VP7 trimers and 120 copies of VP3 (Burroughs et 
al., 1995). The crystal structure of the inner core was 
recently grown up to 0.8 rom in diameter. The dimensions 
are 754 x 796 x 823A3 (Burroughs et al., 1995). The second 
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layer of the inner core contains the remaining three minor 
proteins (V~1, VP4, and VP6) and the genomic dsRNA. A loss 
of infectivity is found after one or two of the outer 
capsid proteins are removed. Both divalent and monovalent 
cations are able to destabilize the outer capsid layer 
(Huismans et al., 1987c). The inner core particles are 
stable at a pH as low as 5, and the virions are the most 
stable at the pH range of 8 to 9. BTV virions are also 
stable ln nonionic detergent and in lipid solvents 
(Huismans et al., 1987c; Mertens et al., 1987; Verwoerd et 
al . , 19 7 9) . 
Verwoerd and his colleagues (1970) separated the 
genome of BTV into 10 segments using polyacrylamide gel 
electrophoresis. The electrophoretic pattern of the 
genomic RNA segments is quite different from that of 
reovirus, and the molecular weight of the BTV genome lS 
estimated to be 19 x 10 6 Da (Fukusho et al., 1989). 
Most dsRNA segments of the five US BTV serotypes have 
been cloned and sequenced recently. The length of segment 
ranges from 3944 to 822 base pairs (bp) . The lengths of 
the corresponding dsRNA segments of each serotype of BTV 
are identical or very similar, and their sequences of 
cognate genes are all highly conserved. A sequence of slx 
nucleotides at the 5'-and 3'- end of all BTV dsRNA segments 
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lS conserved; however, the significance of this sequence 
conservation is still unknown. The migration profiles of 
the genomic dsRNA segments on a polyacrylamide gel are 
different for each BTV serotype. This characteristic can 
be used to distinguish different serotypes of BTV 
diagnostically. 
Viral proteins 
Each of the 10 segments of the viral genome except the 
S4 gene codes for one polypeptide ·(Grubman et al., 1983; 
Sanger and Mertens, 1983; Roy, 1989; Evans-Wade et al., 
1992). The double-layer viral protein coat contains two 
outer capsid proteins (VP2 and VP5) and five inner core 
proteins (VP1, VP3, VP4, VP6, and VP7). Four nonstructural 
proteins (NS1, NS2, NS3, and NS3A) have also been detected 
in BTV-infected cells (Hyatt et al., 1991) and by in vitro 
translation (Grubman et al., 1983; Mertens et al., 1984; 
Van Dijk and Huismans, 1988). The viral structural 
proteins from purified virions can be resolved by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) into 
distinctive patterns for each serotype. Thus, each 
serotype of BTV can be distinguished by comparing the 
electrophorogram patterns in addition to the neutralization 
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assay. The following are the known characteristics of 
these viral proteins. 
VPl protein 
VP1, the largest protein of BTV, 1s one of the minor 
inner core proteins and is coded by the L1 gene. Only six 
copies of VP1 are potentially present in each virion 
(Huismans and Van Dijk, 1990). The L1 gene has 3944 
nucleotides (Huang et al., 1995) and is highly conserved 
among five US BTVs. VP1 is a highly basic protein with a 
positively charged carboxyl terminus. The molecular weight 
of VP1 is estimated to be 150 kDa from the deduced amino 
acid sequences (Huang et al., 1995). 
The deduced amino acid sequence of VP1 has about 30 % 
identity with those of some of the prokaryotic and 
eukaryotic polymerases such as the beta-chain subunits of 
Escherichia coli (E. coli) and Saccharomyces cerevisiae RNA 
polymerase, respectively (Roy et al., 1988). By using the 
cell lysate of Spodoptera frugiperda (SF) cells infected 
with a recombinant baculovirus expressing the VP1 protein, 
labeled ATP was incorporated into the poly(U)-templates, 
indicating that VP1 is a potential BTV RNA polymerase 
(Urakawa et al., 1989). However, there is no report of 
using purified BTV VP1 for the polymerase activity assay, 
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yet. Recently, four of the linear epitopes were mapped at 
amlno acid residues #42-55, #459-473, #881-903, and #1251-
1274 (Huang et al., 1995) using oligoclonal antibodies 
produced in rabbits. 
VP2 protein 
VP2 protein 1s a maJor component of the outer capsid 
of BTV. It is the serotype-specific antigen, and can 
elicit neutralizing antibodies (Huismans and Erasmus, 1981; 
Kahlon et al., 1983). It is also the protein responsible 
for the hemagglutination of red blood cells (Cowley and 
Gorman, 1987). The segment coding for VP2 is the L2 gene 
(Verwoerd et al., 1972). The lengths of L2 genes of the 
five US BTVs are slightly different; 2943 bp in BTV-2 
(Yamaguchi et al., 1988), 2923 bp in BTV-17, 2935 bp ln 
BTV-13, and 2926 bp in both BTV-10 and -11 (Purdy et al., 
1985) . The molecular weight of VP2 is about 111 kDa, and 
there are 180 copies of VP2 per virion, calculated by 
cryoelectron microscopy (Hewat et al., 1992). The deduced 
amino acid sequences of VP2 vary considerably among all 
serotypes. Peptide mapping is further evidence that VP2 1s 
unique for each of the US serotypes (Mecham et al., 1986). 
However, each has a highly conserved carboxyl terminus, 
middle region between amino acid #360-367 (NPYPCLRG), and 
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six conserved cysteines. These conserved regions may be 
responsible for VP2 maintaining its overall structure or 
may be required for interactions with other viral proteins. 
The residue variability for cognate VP2 reflects the role 
of this protein in serotype-specific neutralizing antibody 
production. VP2 purified from SDS-PAGE was not able to 
elicit neutralizing antibodies. However, recombinant VP2 
expressed in insect cells was able to produce neutralizing 
antibodies (Inumaru and Roy, 1987), indicating that the 
neutralizing epitopes could be conformational. Hwang and 
Li (1993) have mapped some of the potential neutralization 
epitopes of BTV-2 (amino acid residues #397-408 and #428-
442), BTV-10 (amino acid residues #199-213 and #248-265), 
BTV-11 (amino acid residues #82-94 and #310-321), and BTV 
17 (amino acid residues #31-43 and #444-464). 
VP3 protein 
VP3 protein is one of the major inner core proteins. 
It is encoded by the L3 gene (2772 bp in length) and is 
highly conserved among serotypes (Hwang et al., 1994). It 
_has been shown to contain a serogroup-specific antigen 
(Huismans and Erasmus, 1981), similar to VP7. From the 
analysis of the deduced amino acid sequences, VP3 has a low 
content of charged amino acids and a high content of 
hydrophobic amino acids (Hwang et al., 1994). The 
9 
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molecular weight of VP3 is about 103 kDa with a pi of 6 
(Hwang et al., 1994), and there are 120 copies of VP3 per 
Vlrlon (Burroughs et al., 1995). It exists as a dimer that 
forms a scaffold upon which the trimers of VP7 reside. 
When VP3 and VP7 (the two major lnner core proteins) were 
co-expressed in a baculovirus expression system, the 
formation of a viral core-like particle (CLP) was found 
(French and Roy, 1990). It was concluded that the assembly 
of the inner core does not require the presence of other 
viral proteins nor the whole viral genome (French and Roy, 
1990) . The methionine at residue #500 and the arginine at 
residue #502 of VP3 were found to oe required for the CLP 
formation (Tanaka and Roy, 1994). The CLP formed by VP3 
and VP7 was shown to bind BTV and non-BTV single-stranded 
RNA (ssRNA) and also DNA. The binding activity was shown 
to reside on VP3 (Loudon and Roy, 1992). 
VP4 protein 
VP4 is one of the mlnor lnner core proteins. An 
estimated 5 to 10 molecules are present per virion 
(Huismans and Van Dijk, 1990). The molecular weight of 
this protein ls about 75 kDa. The segment encoding VP4 lS 
the M1 gene. It has the shortest 5'-noncoding region among 
all BTV genes. Hybridization studies indicated that the 
sequences among BTV are highly conserved. VP4 of BTV-10 
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has a high content of charged amlno acids (Yu et al., 
1987), which is common in many of the nucleic acid binding 
proteins. The function of VP4 is still unknown. In a 
recent study (Le Blois et al., 1992), VP4 has exhibited 
GTP-binding activity in both purified virions and cell 
lysate containing recombinant VP4 expressed ln a 
baculovirus expression system. The 5' ends of the mRNAs of 
BTV are believed to be capped and methylated during 
transcription, like reovirus and rotavirus; however, it has 
never been experimentally demonstrated. Due to the GTP-
binding activity of VP4, it is the prime candidate for the 
guanylyltransferase of BTV. 
VPS Protein 
The segment coding for VPS protein lS the M3 gene 
which has 1638 bp, with an open reading frame that can code 
for 526 amino acids. The molecular weight of this protein 
is about 59 kDa (Purdy et al., 1986; Hirasawa and Roy, 
1990; Oldfield et al., 1991; Yang and Li, 1992). Along 
with VP2, VPS is another major outer capsid protein of BTV. 
VPS is the only structural protein that is glycosylated 
(Yang and Li, 1993) . It was shown that VPS can bind to 
different types of lectins including Galanthus nivalis 
agglutinin (GNA), Sambucus nigra agglutinin (SNA), Peanut 
agglutinin (PNA), and Datura stramonium agglutinin (DSA) 
but not Maackia amurensis agglutinin (MAA) . 
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The functions of VP5 have not been determined. From 
the deduced amino acid sequence analyses of the M3 gene, we 
know that VP5 is very variable (Yang and Li, 1992), but not 
as variable as the VP2 protein. VP5 is enriched with non-
polar amino acids (such as isoleucine and alanine). Unlike 
the VP2 protein, the VP5 protein cannot elicit 
neutralization antibodies against BTV (Marshall and Roy, 
1990) even though it is located in the outer capsid. 
However, Huismans et al. (1983) showed that a mixture of 
VP2 and VP5 induced a higher titer of the neutralizing 
antibodies than VP2 alone. 
Two antigenic epitopes of VP5 were mapped (Yang et 
al., 1992b). One linear epitope was identified between 
amino acid residues #175-189. This epitope is common and 
conserved ln all five US BTV serotypes. The other epitope 
was found to be conformational and located between amlno 
acid residues #33 to #215. 
VP6 protein 
VP6 is one of the mlnor lnner core proteins with a 
molecular weight of 35 kDa (Roy et al., 1990; Hwang et al., 
1992b). It is encoded by the S3 gene, which is 1049 bp in 
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length (Fukusho et al., 1989; Hwang et al., 1992b). There 
are approximately 37 copies of VP6 per virion (Huismans and 
van Dijk, 1990). The sequences of S3 genes among BTVs are 
highly conserved (Hwang et al., 1992b). A single, long ORF 
of the S3 gene is identified in all five US BTVs (Hwang et 
al., 1992b). This ORF encodes a 325-amino acid VP6 of ETV-
10, -11, -13, and -17. However, the ORF coding for BTV-2 
VP6 is only 301 amino acids in length, which is 24 amino 
acids shorter than others. This is due to a shift of an 
initiation codon from nucleotides #28-30 to #100-102. 
Sequence analyses of VP6 have revealed a common motif for a 
helicase. The helicase activity may be involved in 
unwinding the dsRNA genome for the mRNA synthesis. 
However, no such activity has yet been found and reported. 
Hayama and Li (1994) mapped six linear antigenic 
epitopes of VP6 at amino acid residues #35-46, #63-78, 
#181-193, #200-209, #216-227, and #292-302. Four 
additional conformational epitopes were mapped recently 
(Hayama and Li, manuscript in preparation). These epitopes 
are conserved among all five US BTVs. By using recombinant 
VP6 expressed in E.coli, Hayama and Li (1994 and manuscript 
in preparation) have identified the nucleic acid binding 
activity and domains of VP6. · It has been shown that VP6 
binds to ssRNA, ssDNA, dsRNA, and dsDNA. Two domains 
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responsible for dsDNA and dsRNA-binding are mapped at amlno 
acid residues #181-209 and #292-302 near the carboxyl 
terminus. Domains for the ssRNA- and ssDNA-binding were 
also mapped at the same two locations (Hayama and Li, 
manuscript in preparation) . 
VP7 protein 
VP7 is the maJor lnner core protein, with a molecular 
weight of 38 kDa. The protein comprises 36% of the total 
core proteins (Huismans et al., 1987c). It has serogroup-
specific antigenic determinants (Huismans and Erasmus, 
1981; Gurnm and Newman, 1982). The segment coding for VP7 
is the S1 gene, which is 1156 bp in length. The S1 gene 
has an ORF capable of coding for 349 amino acid residues. 
The sequences of S1 genes and the deduced amino acid 
sequence for each VP7 are highly conserved among all five 
US BTVs. Only a single lysine residue is located at amlno 
acid residue #255 in VP7, determined from the deduced amino 
acid sequence. By using endoproteinase lys-e to digest all 
five US BTVs VP7 proteins, the presence of this single 
lysine residue of VP7 was confirmed (Li and Yang, 1990) . 
VP7 is very hydrophobic, reflecting its location and 
interior preference. However, Hyatt and Eaton (1988) and 
Lewis and Grubman (1990) showed that monoclonal antibodies 
against VP7 reacted with intact virions, and concluded that 
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a portion of the VP7 extrudes to the surface of the BTV 
virion. Si~ilar results were obtained by immunoelectron 
microscopy (Eaton et al., 1991). VP7 was clearly shown to 
be myristylated when BTV was purified from infected BHK-21 
cells containing 3H-myristic acids in the medium (Huang and 
Li, unpublished observation) . It seems that VP7 is the 
only major myristylated structural protein of BTV. The 
significance of this posttranslational modification is 
still unknown. 
Five linear antigenic epitopes were mapped at amino 
acid residues #1-60, #207-240, #256-275, #339-349, and 
#122-139 (Li and Yang, 1990; Wang et al., 1996). These 
epitopes were highly conserved among the VP7 proteins of 
all five US BTVs. In addition to the linear epitopes, one 
conformational and potential serogroup-specific 
immunodominant epitope was identified at the N-terminus of 
VP7 proteins between amino acid residue #30 and 48 (Wang et 
al. , 19 94) . 
VP7 proteins exist in the inner core as trimers (780 
copies per virion) . Recently, VP7 was crystallized and 
analyzed at 2.6A resolution. In this study it was shown 
that VP7 consists of two domains, one aB-sandwich, the 
other a bundle of a-helices, and a short carboxy-terminal 
arm (Grimes et al., 1995). The carboxy-terminal arm is 
predicted to tie the trimers together during capsid 
formation. A new study has shown that VP7 proteins are 
orientated with their N-terminus accessible on the surface 
of the intact virion by immunoelectron microscopy (Wang et 




There are four nonstructural proteins found in BTV-
infected cells. NS1 and NS2 are the two major non-
structural proteins, whereas NS3 and NS3A are barely 
detectable. NS1 protein is synthesized in large amounts and 
represents about 25% of the total virus-specified protein 
in infected cells. It forms high molecular weight tubular 
structures (Huismans, 1979; Huismans and Els, 1979) . These 
tubules are formed in the cytoplasm of BTV-infected cells 
as early as 4 hr postinfection (Huismans, 1979) and before 
the formation of the significant amounts of virus inclusion 
bodies (VIBs) and viral progeny (Hyatt et al., 1989). From 
electron microscopic studies of BTV-infected cells it was 
evident that these tubules accumulate late in infection, 
particularly in peri-orjuxtonuclear locations. The segment 
coding for NS1 is the M2 gene, which is 1769 bp in length 
(Lee and Roy, 1987; Grubman and Samal, 1989; Wang et al., 
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1989; Hwang et al., 1993). This gene has an ORF with a 
coding capacity of 552 amino acids (64 kDa). From sequence 
analyses, the nucleoti~e sequence identity of M2 genes 
among five US BTVs is between 92 to 99%; the deduced amino 
acid sequence identity of NS1 is between 96-99% (Hwang et 
al., 1993). NS1 is rich in cysteine residues, and all 16 
cysteines are conserved in the cognate NS1 proteins of 
different BTV serotypes. This indicates the probability 
that NS1 may have highly ordered disulfide bonds. 
Two cysteines (amino acid residues #337 and 340) 
located in a hydrophilic region of NS1 were found to be 
required for tubule polymerization (Monastyrskaya et al., 
1994). In addition to these two cysteines, the first 10 
amino acids in the amino-terminus and the 20 amino acids 1n 
the carboxy-terminus are also required for the tubule 
polymerization in insect cells that were infected by 
baculovirus expressing recombinant NS1 (Monastyrskaya et 
al., 1994). The mutated NS1 proteins in the infected 
insect cells made ribbon-like structures instead of tubular 
polymers. 
Eaton et al. (1987) reported that NS1 was detected in 
cytoskeleton-associated virus particles, purified virions, 
and core particles; and suggested that viral morphogenesis 




NS2 protein lS the nonstructural protein that forms 
VIEs in the cytoplasm of BTV-infected cells. It is the 
only BTV protein that lS phosphorylated (Huismans et al., 
1987b; Devaney et al., 1988). The segment that encodes for 
NS2 is the S2 gene, which contains 1125 nucleotides (Yang 
et al., 1992a) with an ORF coding for 354 amlno acid 
residues. The molecular weight of NS2 is about 41 kDa from 
the deduced amino acid sequence. The protein lS 
hydrophilic and rich in charged amino acids. Two of the 
linear antigenic epitopes were mapped at amino acid 
residues #153-166 (DIRELRQKIKNERE) and #274-286 
(EKVAKQIKLKDER) (Huang and Li, unpublished observation) . 
NS2 from BTV-infected cells (Huismans et al., 1987b), 
recombinant NS2 ·expressed in insect cells (Thomas et al., 
1990), and recombinant NS2 expressed in E. coli (Li et al., 
unpublished observation) has the ability to bind BTV mRNA 
and non-BTV ssRNA but not dsRNA. The potential function of 
NS2 lS the selection and condensation of the BTV mRNAs 
during viral morphogenesis. 
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The ssRNA-binding activity of the NS2 protein has been 
intensively studied. Recently, the ssRNA-binding domains 
of the NS2 protein were identified at the amino terminus 
(Zhao et al., 1994). Point-~utational studies indicated 
that the arginines at amino acid residues #6 and #7 and the 
lysine at residue #4, but not the glutamic acid at residue 
#2, are involved in ssRNA-binding. However, in our 
laboratory, there are another three potential ssRNA-binding 
domains that have been mapped at amino acid residues #2-11, 
#153-166, and #274-286 (unpublished observation) . By 
deletion it has been shown that neither the amino- nor 
carboxy-terminus of NS2 is involved in VIB formation (Zhao 
e t al. , 19 9 4) . 
NS3/3A Protein 
The other nonstructural proteins of BTV are NS3 and 
NS3A. Both proteins are synthesized in small amounts and 
at the late infection stage. Both of them are encoded by 
the smallest segment of BTV dsRNA, the S4 gene (Mertens et 
al., 1984; Van Dijk and Huismans, 1988). The S4 gene is 
·822 bp in length and has two long, in-phrase open reading 
frames (Hwang et al., 1992a). 
The in vitro translation products of S4 mRNA contain 
two proteins, NS3 and NS3A, with a molecular weight of 28 
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and 25 kDa, respectively. The two proteins are produced by 
the two in-phase ORFs of the S4 gene. The two proteins 
have almost identical peptide maps and are synthesized 1n 
very small amounts in BTV-infected cells (Van Dijk and 
Huismans, 1988). After the first AUG was qeleted, only 
NS3A was synthesized but NS3 was not synthesized (Wu et 
al., 1992). From the deduced amino acid sequences of NS3, 
at least two conserved hydrophobic domains at amino acid 
residues #118-147 and #156-182 among all five US BTVs may 
represent transmembrane domains. Hyatt et al. (1991), 
using immunoelectron microscopic studies, reported that NS3 
and NS3A are associated with intra-cellular, smooth-
surfaced vesicles, and with the plasma membrane. 
In a recent study by Wu et al. (1992), NS3 and NS3A 
were identified as N-linked glycoproteins containing high-
mannose sugars such as polylactosaminoglycans. In this 
study it was also suggested that the carbohydrate chains 
are not required for the NS3 to be transported to the cell 
surface. 
The function(s) of NS3 and NS3A are still unknown. A 
hypothesis is that they are involved in the release of BTV 




BTV replicates in the cytoplasm of infected cells and 
infection finally leads to cell death. The mechanism of 
BTV replication is still largely unknown. BTV is taken up 
by endocytosis after attachment to cells (Lecatsas, 1968; 
cromack et al., 1971). The binding of BTV to cells is 
mediated by the outer capsid protein VP2 (Huismans et al., 
1983). However, the viral receptor has not been 
identified. The virus adsorbs to ~usceptible cells within 
20 min at both 4° C and 37°C (Huismans et al., 1983). This 
suggested that the membrane fluidity of the infected hosts 
is not involved in the entry of BTV. The outer coat 
protein VP2 is then removed in endosomes within 1 hr of 
infection (Huismans et al., 1987c). VPS is probabiy 
removed at the same location, also prior to release of the 
core particle into the cytoplasm. The release of virus 
from endosomes is dependent on the low pH within this 
organelle. Increasing the pH of endosomes by adding NH4Cl 
and methylamine (weak bases} inhibited the entry of 
endocytosed virus particles into the cytoplasm (Ohkuma and 
Poole, 1978). In the cytoplasm, core particles of BTV bind 
to intermediate filaments (Eaton et al., 1987; Eaton and 
Hyatt, 1989) and transcribe virion mRNAs (Bowne and Jochim, 
1967 ) · The transcriptase activity of virions requires the 
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removal of both outer capsid proteins (VP2 and VP5) (Van 
Dijk and Huismans, 1980). Th~ mRNA species are synthesized 
at different rates (Huismans and Verwoerd, 1973). The NS1 
mRNA seems to be the most abundant in the early stage of 
infection. Huismans et al. (1987c) suggested that the 
transcriptase activity of the core particle may be active 
for a limited time, and unlike reovirus, core particles do 
not reassociate with newly synthesized outer coat proteins 
to release from cells as progeny virus. Translation then 
occurs, using the newly transcribed mRNAs. The generated 
viral proteins appear to condense with single strand-RNAs 
(ssRNAs) to form core-like particles, which ultimately 
aggregate to generate viral inclusion bodies (VIBs). The 
new viral core particles are made within the VIB matrix 
(Hyatt et al., 1989). Complementary RNAs will then be 
synthesized using the plus-sense RNAs as templates to 
complete the formation of dsRNAs. By studying the s1ze and 
density of the particles, it has been suggested that the 
particles leaving the VIB contain dsRNAs; therefore, BTV 
replicase may be found within the VIB. A portion of the 
outer coat proteins is added to the core particles and the 
remainder may follow when the virus leaves the VIBs. The 
morphogenesis of BTV occurs within the VIBs, and a high 
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proportion of viral progeny remains associated with cell 
debris (Howell and Verwoerd, 1971). 
Diagnosis of bluetongue 
disease 
The clinical diagnosis of bluetongue disease in sheep 
is uncomplicated for an experienced clinician (Gibbs, 
1983) . The diagnosis of this disease in cattle is often 
clinically unnoticeable, and it is very easily confused 
with other diseases such as malignant cattarhal fe.ver and 
bovine virus diarrhea/mucosal disease. Isolation of BTV 
from infected animals is difficult for diagnosis. 
Detection of antibodies to BTV is based on group-reactive 
tests (including complement-fixation, ELISA, fluorescent-
antibody, etc.) and the serotype-specific neutralization 
tests (Pearson et al., 1985). In a recent report it was 
indicated that competitive enzyme-linked irnrnunosorbent (C-
ELISA) can be used as a rapid and specific test for 
serodiagnosis of BTV infection in llamas and other wild 
ruminants (Afshar et al., 1995). 
The most common antigens used for detecting BTV 
antibodies in infected animals are NS1 (Urakawa and Roy, 
1988; He et al., 1991) and VP7 (Lunt et al., 1988). In the 
study done by He et al. (1991), sheep anti-NSl antibodies 
were raised with the recombinant NS1 expressed in E. coli 
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and used to detect the NSl proteins of the five US BTVs. 
The immunological activity of the antibody was 
indistinguishable between native and recombinant NSl. This 
i ndicated that NS1 can be used as a group-specific antigen 
ln the diagnosis of BTV infections, in addition to VP7. 
New techniques have been developed for the detection 
of BTV in biological specimens. These methods include 
polymerase chain reaction (PCR) and nucleic acid 
hybridization (Wade-Evans et al., 1990; Venter et al., 
1991). Wade-Evans et al. (1990) used a group of primers 
designed complementary to the termini of the 10 dsRNAs of 
South Africa BTV serotype 1 (BTV-1SA) to amplify each 
individual segment. They found that the S1 gene gave the 
best amplification results. This primer was able to 
amplify the S1 gene from red blood cells (RBC) and buffy 
coat samples from cattle which were infected with BTV-4. 
Venter et al. (1991) also determined the genomic probes of 
BTV that can give the best sensitivity to detect BTV-
specified RNA in infected cells. They found that the probe 
derived from the genome segment that encodes NS1 (M2 gene) 
to be the most sensitive. It could detect BTV-specified RNA 
ln cells as early as two to three hr postinfection, and it 
could also be used to analyze the cells infected at very 
low multiplicities of infection (M.O.I.). The great 
sensitivity of this probe is due to M2 mRNA, the target of 
the probe, which is transcribed more frequently than other 
viral mRNAs. Similar types of experiments were also shown 
in epizootic hemorrhage disease virus (EHDV) and 
encephalitis virus (EEV). 
Vaccine development 
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Development of a vaccine against BTV took place as 
early as 1908 (Theiler, 1908). This was accomplished by 
immunizing sheep with an attenuated strain of BTV that had 
been serially passaged in sheep. Chemically inactivated 
viruses were also used for the vaccination. Unfortunately, 
these have been shown unsafe and unsuccessful (Neitz, 1948; 
Mahrt and Osburn, 1986a; Mahrt and Osburn, 1986b) due to 
the capability of the viruses to reassort in mixed 
infections. 
Huismans et al. (1987a) had shown that purified VP2 
alone could elicit neutralizing antibodies against BTV and 
protect the animal challenged with the same serotype BTV. 
Inumaru and Roy (1987) and Marshall and Roy (1990) used 
recombinant BTV neutralizing antigen(s) expressed in insect 
cells to produce neutralizing antibodies against BTV. 
However, these types of approaches are expensive and only 
protect the homologous but not heterologous BTV serotypes. 
Another approach has been investigated using synthetic 
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peptides as subunit vacclne. Synthetic peptide vaccine has 
the advantages of being inexpensive, stable, and can 
produce high titer antibodies. If a common neutralization 
epitope of BTV serotypes is identified, it can be used as a 
subunit vaccine to protect animals from all BTV serotypes. 
JUSTIFICATION AND OBJECTIVES 
Unlike reovlrus, the replication of BTV is still not 
clear. Many of the assumptions regarding mRNA synthesis 
and genomic RNA replication are based on information 
obtained from reovirus research. After the outer coat 
proteins are removed from the virion, the transcriptase lS 
activated and transcribes mRNAs uslng the dsRNA genome 
segments as templates (Van Dijk and Huismans, 1980; Martin 
and Zweerink, 1972). The mRNAs are capped and translated 
to viral proteins. The mRNAs are also used as templates 
for synthesizing negative-sense RNAs to form the dsRNA 
genome. All 10 segments of dsRNA are always sorted in a 
single virion. These characteristics of BTV transcription 
and replication are considered to be the functions of the 
lnner core minor proteins. However, the functions of the 
lnner core proteins are still unknown. To understand these 
phenomena, each of the inner core proteins has to be 
characterized, and their functions have to be identified. 
VPl expressed as a recombinant protein in the 
baculovirus expression system_ has a potential RNA 
polymerase activity. It might be an RNA-dependent RNA 
polymerase of BTV (Urakawa et al. 1989). VP6 recently has 
been characterized as a nucleic acid binding protein 
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(Hayama and Li, 1994 and manuscript in preparation) . It 
has a nonselective nucleic acid binding activity ~n vitro. 
VP4, a minor component in the inner core of BTV, 1s encoded 
by the M1 gene. Huismans (1979) suggested that only 5 to 
10 molecules of VP4 are present in each virion. Very 
little information is known about the function(s) and 
characteristics of VP4. The only information known 
regarding the function of VP4 is that both viral and 
recombinant VP4 expressed in a baculovirus expression 
system have GTP-binding activity (Le Blois et al., 1992). 
VP4 1s potentially a guanylyltransferase of BTV. 
The objective of my study is to investigate the 
function of VP4. I will determine the nucleic acid 
sequence of the M1 gene that codes for VP4. Based on the 
deduced amino acid sequence, I plan to locate some of the 
potential functional motifs of VP4 by comparing its amino 
acid sequence with other known sequences and to perform 
structural and functional analysis of these domains. This 
information will reveal the potential role(s) of VP4 1n 
vlrus replication and morphogenesis. I will also compare 
the VP4 sequences of five US BTV serotypes to identify the 
conserved and probably essential domains of VP4 which may 
be required for its function. 
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In our laboratory we have determined the genetic 
relationships among BTV serotypes (Kowa~ik and Li, 1989; 
Kowalik et al., 1990; Hwang et al., 1992a; Hwang et al., 
1992b; Yang and Li, 1992; Yang et al., 1992a; Hwang et al., 
1993; Hwang et al., 1994; Huang et al., 1995). Sequencing 
the M1 genes of all five US BTV serotypes will produce 
further information for phylogenetic analysis of the US BTV 
serotypes. 
Because only a small amount of VP4 is present in the 
Vlrus, it is very difficult, costly, and time-consuming to 
obtain this protein from the purified virus and elucidate 
its potential function(s). Recombinant VP4 will be used in 
this study. 
The specific alms of this study are: 
(1) To clone and determine the nucleotide sequences of 
the M1 gene that codes for VP4 of five US BTV serotypes. 
(2) To compare the phylogeny of five US BTV serotypes 
by analyzing their five M1 gene sequences. 
(3) To express and puri .fy recombinant VP4. 
(4) To map and characterize some of the functional 
domainE of VP4. 
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CHAPTER II 
CONSERVATION OF THE Ml (SEGMENT 4) GENE SEQUENCE 
AND OF A LEUCINE ZIPPER MOTIF IN VP4 AMONG 
FIVE US BLUETONGUE VIRUSES1 
ABSTRACT 
Full-length eDNA coples of the M1 (segment 4) genes of 
US bluetongue viruses serotype-2, -10, -11, -13, and -17 were 
selectively amplified using genomic double-stranded RNA 
segments from purified BTV virion~ as templates and a 
modified polymerase chain reaction (Clamp-R) . They were 
cloned into pUC19 plasmids and both strands of several clones 
were sequenced. The length of all five M1 genes is 1981 
nucleotides. The result ls contrary to the M1 gene of 
serotype-10 sequenced by Yu et al. (1987), which has 2011 
nucleotides. The 5'- and 3'-noncoding regions of M1 genes 
are identical among all serotypes. The plus sense strand of 
the BTV M1 gene, which encodes the VP4 protein, possesses a 
single, long open reading frame (ORF) with an initiation 
codon (ATG) at nucleotides #9-11 and a stop codon (TAA) at 
nucleotides #1941-1943. This ORF encodes for a protein of 
644 amino acid residues with a predicted molecular weight of 
about 75 kDa and a pi of +7 to +7.9. A potential leucine 
I BTV-2 and BTV-11 M1 genes were cloned and sequenced by Dr. E. Hayama 
and Ms. Y. Jeong, respectively. 
Zlpper motif was detected near the carboxyl terminus of the 
deduced VP4 amino acid sequence. The phylogeny established 
using the sequences of these five cognate M1 genes is 
consistent with the results of our prevlous phylogenetic 
studies of cognate genome segments 5, 6, 8, 9, and 10. 
Serotype-10, -11, -13, and -17 are closely related and 




Bluetongue Vlrus (BTV), classified in the Orbivirus 
genus of the family Reoviridae (Borden et al., 1971; Murphy 
et al., 1971), is an arthropod-borne virus that causes the 
bluetongue disease in domestic and wild ruminants. This 
disease was first discovered in South Africa more than a 
century ago and then found in various other parts of the 
world after 1949. BTV is an icosahedral-shaped particle 
consisting of a double-layered protein coat. Its genome lS 
composed of 10 segmented double-stranded RNAs (dsRNAs) 
(Verwoerd et al., 1972). Each segment of the viral genome 
except the S4 gene encodes a single protein (Grubman et 
al., 1983; Sanger and Mertens et al., 1983; Roy, 1989). 
The double-layer viral protein coat contains two outer 
capsid proteins (VP2 and VP5) and five inner capsid 
p r o te ins (VPl, VP3, VP4, VP6, and VP7). Four nonstructural 
p r oteins (NSl, NS2, NS3, and NS3A) have also been detected 
i n BTV-infected cel l s (Hyatt et al., 1991) and by in vitro 
t ranslation (Grubman et al., 1983; Mertens et al., 1984; 
Van Dijk and Huismans, 1988). 
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VP4, a minor coffiponent of the inner capsid of BTV, 1s 
encoded by the M1 (segment 4) gene. Little is known about 
the structure and function of VP4. To gain a better 
understanding and to investigate the potential biological 
function(s) of this protein as well as the evolutionary 
relationship of the five US bluetongue v1ruses, the M1 
genes of BTV serotype-2, -10, -11, -13, and -17 were cloned 
and sequenced. 
MATERIALS AND METHODS 
Virus preparation 
The seed stocks of the five US BTV serotypes were 
provided by Arthropod-Borne Animal Disease Research 
Laboratory of USDA. They were three times plaque-purified 
in L-929 as described by Kowalik and Li (1987). The 
viruses were propagated in baby hamster kidney (BHK-21) 
cells grown in roller bottles (Corning) at a multiplicity 
of infection (M.O.I.) of 1. Viral particles were purified 
by using sucrose gradients as described by Kowalik and Li 
(1989) and Kowalik et al. (1990). BTV-infected cells were 
scraped fro~ roller bottles 2 days postinfection and 
pelleted at 3000x g for 25 mln. The pellets were then 
resuspended in NTE (200 mM Tris-HCl, pH 8, 100 mM NaCl, 2 
mM EDTA) buffer containing 1% (w/v) Triton .X-100 and 0.5% 
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(w/v) deoxycholate. After 10 min of incubation at room 
temperature, insoluble particles were removed by 
centrifuging at 2000x g for 5 min at room temperature. The 
virus containing supernatant was then loaded onto a 40% 
(w/v)/60% (w/v) sucrose step gradient containing 200 mM 
Tris-HCl (pH 8) and centrifuged for 90 min at 37,500 rpm ln 
a Beckman SW41Ti rotor. At the end of centrifugation, the 
partially purified viruses located at the interface of the 
two sucrose solutions were collected and resuspended in 200 
mM Tris-HCl (pH 8) containing 1% (w/v) N-lauroyl sarcosine 
and 10 mM dithiothreitol (DTT). The virus suspenslon was 
incubated at 37° C for 30 min and pelleted through a 1-cm 
40 % (w/v) sucrose cushion as described above. The purified 
vlruses were then resuspended in 200 mM Tris-HCl (pH 8) and 
kept at -20° C. Each individual serotype was confirmed by 
neutralization assays and by comparing the characteristics 
electrophorograms of the viral proteins and dsRNAs on 10% 
SDS-PAGE (Li et al., 1989). 
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Preparation of genom~c dsRNA 
The total dsRNA was extracted from the viral particles 
by the SDS-KCl method according to Li et al. (1989) and 
Kowalik et al. (1990). SDS was added to the purified virus 
solution to a final concentration of 1% SDS. The mixture 
was then boiled for 1 mln and chilled on ice for 5 min. An 
equal volume of 0.5 M KCl was added to the mixture, and the 
mixture was kept on ice for another 5 min. The viral 
proteins and genomic dsRNA were separated by centrifuging 
at 10,000x g for 10 min (4 ° C) in a microcentrifuge. The 
dsRNA in the supernatant was then purified by 
phenol/chloroform extraction and ethanol precipitation at 
-20° C for 1 hr. The dsRNA was pelleted by centrifuging at 
10,000x g for 10 mln. The pellet was washed with 70% 
ethanol and dried under vacuum. The dsRNA pellet was then 
dissolved in double distilled water (ddH20) and kept at -20° 
C until use. 
Amplification of the 
cognate Ml cDNAs 
The full-length cDNAs of M1 genes were amplified uslng 
the purified BTV dsRNA as templates by the Clamp-R method 
(Kowalik et al., 1990). A pair of primers, containing 
sequences complementary to the termini of BTV-11 M1 gene 
(Kiuchi et al., 1983) and anchored with a Psti restriction 
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enzyme site (5'-AGTCGACCTGCAGGTTAAAACATGCCTGAG-3' a n d 5'-
AGTCGACCTGCAGGTAAGTTGTACATGCCC-3'), was used to 
specifically amplify the full-length eDNA of the Ml genes 
from each BTV-2, -10, -11, -13, and -17. A solution (20 pl 
total) containing 0.3 pg of dsRNA templates and 0.5 pg of 
primers was boiled for 4 min and then chilled on lee 
immediately. The template-primer mixture was then mixed 
with 1 pl of 10 rnM dNTP, 5 pl of lOx buffer (100 rnM Tris-
HCl, pH 8.3, 0.5 M KCl, 15 mM MgC1 2 , and 0.1% (w/v) 
gelatin), 0.5 pl (12.5 units) of avian myeloblastosis 
virus-reverse transcriptase (AMV-RT) (Promega), and 0.5 pl 
(2.5 units) of native Taq DNA polymerase. The mixture was 
then overlaid with 100 pl of mineral oil to prevent 
evaporation. The amplification was carried out in a 
programmable thermal cycle reactor (Ericomp Corp.). First-
strand eDNA was synthesized at 42 ° C by AMV-RT for 1 hr and 
subsequently amplified by 35 cycles of amplification, which 
included denaturation (95° C for 2 min), annealing (37 ° C for 
2 min), and extension (72 ° C for 10 min). A final extension 
was done at 72 ° C for 20 min. 
Cloning of Ml cDNAs 
The amplified full-length cDNAs of Ml genes were 
restricted with Psti endonuclease and electrophoresed 
through a 1% low melting point agarose gel with O.Sx TBE 
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buffer (lx TBE is 90 mM Tris-borate, pH 8, 2 rnM EDTA). The 
band containing the full-length Ml eDNA was excised from 
the gel and melted at 55° C for 5 min. Fifteen pl of the 
gel solution containing M1 eDNA was ligated with Psti-
digested pUC19 vector in a final 50 pl of ligation mixture 
[containing 5 units of T4 DNA ligase, 1x ligation buffer 
(50 mM Tris-HCl, pH 7.8, 10 mM MgC1 2 , 10 mM DTT, 1 mM ATP, 
2.5 pg/ml BSA)] (NEB) at room temperature for 2 hr. Ten pl 
of the ligation mixture was mixed with 100 pl of 50 mM CaCl z 
and 30 mM MgCl z and then used to transform 100 pl of 
competent E. coil strain XL-1 blue. The mixture was 
incubated on ice for 40 min, heat shocked at 42 ° C for 2 
min, and grown ln 0.8 ml of LB (10 g tryptone, 5 g yeast 
extract, 5 g NaCl per litter) at 37 ° C for 1 hr. The E. 
coli culture was then plated on LB plates containing 1% 
agar, 50 pg/ml ampicillin, 0.1 mM isopropyl-1-thio-D-
galactoside (IPTG), and 20 pg/ml 5-bromo-4-chloro-3-
indolyl-D-galactoside (X-gal). After 16 hr incubation at 
37 ° C, white colonies were picked and grown in LB containing 
ampicillin for plasmid isolation. About 1.5 ml of 
overnight E. coli culture was pelleted by centrifuged at 
10,000x g for 20 sec at room temperature. The cells were 
resuspended in 100 pl of lysis buffer (25 mM Tris-HCl, pH 
8, 10 mM EDTA, 50 mM glucose) and incubated at room 
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t~mpe rature for 5 m1n. The suspens1on was then mixed with 
200 pl of freshly prepared alkaline solution (0.2 N NaOH, 
1 % SDS) and incubated on ice for 5 m1n. The mixture was 
t hen mixed with 150 pl of ice-cold potassium acetate (pH 
4.8) and incubated on 1ce f8r 5 min. The plasmids were 
separated from the cellular debris by centrifuging at 
10,000x g for 5 min at 4° C. RNAse A was added to the 
supernatant to a final concentration of 20 pg/ml to digest 
cellular RNA for 30 min at 37 ° C. An equal volume of 
phenol/chloroform was added to the mixture, vortexed, and 
centrifuged at 10,000x g for 2 m1n. The plasmids in the 
supernatant was mixed with 2.5x volume of cold 100% ethanol 
(-20° C) and incubated at -80° C for 1 hr. The plasmids were 
pelleted by centrifuging at 10,000x g for 10 min at 4° C and 
washed with 70% ethanol. The DNA pellet was dried under 
vacuum and dissolved in TE. The presence of the M1 gene 
insert in the plasmids was checked by digesting with Fsti 
restriction enzyme and analyzed by 1 % agarose gel 
electrophoresis. 
DNA sequencing 
Plasmids were purified from 50 ml of overnight E. coli 
culture as described above except that they were further 
purified with polyethylene glycol (PEG). Plasmids were 
then dissolved in 168 pl of ddH20 and mixed with 32 pl of 5 
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M NaCl and then 200 pl of 13% PEG. The mixture was kept on 
lee for a minimum of 30 min and centrifuged at 10,000x g 
for 10 min at 4° C. The DNA pellet was then washed with 70 % 
ethanol, dried under vacuum, then dissolved in TE and kept 
at -20° C until use. 
One pg of plasmid DNA in 40 pl of water was mixed with 
4 pl of denaturation solution (2 N NaOH, 2 mM EDTA) and 
kept at room temperature for 5 min. After the incubation, 
16 pl of ddH20 and 6 pl of 3M sodium acetate (pH 4.6) were 
added to the denatured DNA solution sequentially. To 
precipitate the DNA, 150 pl of cold 100% ethanol (-20° C) 
was added to the mixture, mixed, and kept at -80° C for 20 
mln. The denatured DNA was pelleted by centrifuging at 
10,000x g for 5 mln. The pellet was rinsed with 70% 
ethanol (-20 ° C) and vacuum dried. DNA was then dissolved 
in 7 pl of ddH20 and kept on ice until use. To start the 
annealing reaction, 1 pl of primer (0.5 pmole/pl) and 5 pl 
of reaction buffer (200 mM Tris-HCl, pH 7.5, 100 mM MgC1 2) 
were added to the 7 pl DNA solution. The primer-template 
mixture was kept at 37° C for 30 min. For the labeling 
reaction, 1 pl of 0.1 M DTT, 2 pl of diluted label~ng mlx 
(1.25 pM dGTP, 1.25 pM dCTP, and 1.25 pM dTTP) (USB), 0.5 
pl of [a- 35S]-dATP (10 pCi/pl) (Amersham), and 2 pl of 
diluted sequenase (USB) were added to the primer-template 
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mixture; the reaction was carried out at room temperature 
for 5 min. The termination procedure was started by 
transferring 3.5 pl of the previous solution to each of the 
four termination m1xes (ddATP, ddCTP, ddGTP, ddTTP), which 
were pre-warmed at 37° C and incubated at 37° C for 5 min. 
The reaction was stopped by adding 4 pl of stop solution 
(95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% 
xylene cyanol-FF) . The DNA mixtures were denatured at 80° C 
for 2 min and chilled on ice immediately before loading 
into a 5% polyacrylamide sequencing gel (acrylamide : bis-
acrylamide, 30:1) containing 7 M urea. Five pl from each 
of the mixtures were loaded into a single lane. 
Electrophoresis proceeded at 2000 volts with 1x TBE buffer 
until the desired separation was reached. The temperature 
of the sequencing gel was kept at 55° C during the entire 
run. The sequencing gel was soaked in fixing solution (5% 
acetic acid, 15% methanol) for 15 min to fix the DNA and 
remove urea. The gel was then dried using a slab gel drier 
(Bio-Rad, Model 483) for 2 hr at 80° C. The dried gel was 
exposed with Kodak XAR-5 film at room temperature for 
autoradiography. Both strands of the inserted genes of 




Molecular phylogeny was analyzed by the PILEUP program 
l n the GCG software (Devereux et al., 1984) using both the 
nucleotide and deduced amino acid sequences of the entire 
M1 genes. 
RESULTS 
The full-length cDNAs of 5 BTV M1 genes were amplified 
(Fig. 1) using the purified BTV dsRNA as templates by the 
Clamp-R method. The amplified e DNA has a similar size as 
that of M1 gene dsRNA segment (about 2000 bp) . The eDNA 
was digested with Psti restriction enzyme and cloned into 
pUC19 plasmid for sequenclng. 
All of the cloned eDNA of M1 genes were full-length 
except BTV-2, which has one Psti restriction enzyme site at 
position #1786-1790. The M1 gene of BTV-2 was cloned as 
two fragments in pUC19 at Psti site. 
The M1 gene of each US BTV is 1981 nucleotides. They 
are highly conserved and can be aligned without any gaps 
(Fig. 2). A single long, ORF was found ln the M1 gene of 
BTV-2, -10, -11, -13, and -17 with a start codon (ATG) at 
nucleotides #9-11 and a stop codon (TAA) at nucleotides 
#1941-1943. This ORF has a coding capacity of 644 amino 
acids and is flanked with an 8-nucleotide noncoding region 
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at its 5'-end and a 38-nucleotide noncoding reglon at its 
3'-end, respectively. Both ends of the noncoding regions 
perfectly matched among all five US BTV serotypes. The 
coding sequences of Ml genes of BTV-2, -10, -11, -13, and -
17 could also be aligned without any gaps. Yu et al. 
(1987) reported that the sequence of BTV-10 Ml gene 
contained 2011 nucleotides instead of the 1981 nucleotides 
determined in this study. The difference is the presence 
of a direct repeat of 30 nucleotides at #1610-1639. This 
repeat was not found in the BTV-10 Ml gene examined in this 
study. 
The deduced amlno acid sequences of VP4 are aligned 
and shown in Fig. 3. There is a high degree of sequence 
identity (96-99%). Hydropathy analysis indicates conserved 
hydrophobic amino and hydrophilic carboxyl termini. The 
VP4 proteins have an estimated molecular weight of 75-76 
kDa and a pi between 7 to 7.9 (Table 1). The predicted VP4 
. 
of BTV-2, -10, -11, -13, and -17 has 644 amino acid 
residues, 10 fewer than that of BTV-10 reported by Yu et 
al. (1987). The 10 extra amino acids of BTV-10 VP4 are 
resulted from the 30 extra nucleotides in the sequence. The 
deduced protein contains about 32% charged amino acid 
residues and very little cysteine and glutamine (Table 1). 
52 
Phylogenetic analysis of the five US BTV serotypes was 
performed using both nucleotide and deduced amino acid 
sequences as shown in Fig. 4. The results are summarized 
~n Table 2. The nucleotide sequences of the M1 gene of the 
five US BTVs are highly conserved. The M1 genes of BTV-11 
and -17 has the highest identity of 99.44% (only 10 out of 
1981 nucleotides mismatches). The M1 gene of BTV-2 lS the 
most distantly related among the five US BTVs (Table 2 and 
Fig. 4). 
DISCUSSION 
The full-length cDNAs of the M1 genes were amplified 
by PCR from all five US BTV serotypes-2, -10, -11, -13, and 
-17 (Fig. 1). The M1 genes of all five US BTVs are highly 
conserved containing 1981 nucleotides and could be aligned 
without any gaps (Fig. 2). 
The M1 genes of BTV-11 and -17 had the highest 
identity of 99.44% (10 mismatches out of 1981 nucleotides). 
The M1 gene of BTV-2 is more distantly related to the other 
four US BTV serotypes than the four are among themselves 
(Table 2 and Fig. 4). 
Even though the nucleotide identity among these five 
US BTV serotypes ranged between 89-99%, the amino acid 
sequence mismatches were less than 4%. The reason for this 
difference is that most of the nucleotide mismatches are 
found in the third base codon position (Table 3). The M1 
gene of BTV-2 has 68-71 % relatedness to the other four 
serotypes in the third base codon position calculated by 
the method described by Wiener and Joklik (1987). The M1 
genes among the BTV-10, -11, -13, and -17 are very closely 
related (>97 % identity) and they have more than 93% 
identity even at the third base codon position of codons 
(Table 4). An interpertation of these analyses is that 
BTV-2 diverged from the ancestor of the other four US BTV. 
This result is consistent with the conclusion derived from 
our previous studies of segments 1; 3 5, 6, 8, 9, and 10 
(Hwang et al., 1992a; 1992b; Yang et al., 1992; Yang and 
Li, 1992; Hwang et al., 1993; 1994; Huang et al., 1995). 
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In this study, we reported the M1 genes contain 1981 
nucleotides instead of 2011 reported in BTV-10 by Yu et al. 
(1987). We concluded that the difference is due to a 
direct repeat of 30 nucleotides at #1610-1639. The repeat 
also caused the increase of 10 amlno acid residues of BTV-
10 VP4 that they had reported. This was not found ln the 
BTV-10 sequence of this study. 
Analysis of the deduced amino acid sequences of VP4 
revealed several interesting predicted structures and 
functions. Potential amidation and glycosylation sites 
were found at position #106-109 (IGRR) and #459-462 (NGSY) 
of all five serotypes, respectively. Six potential N-
myristylation sites were also found in VP4 at position 
#297-302 (GGAFSS), #298-303 (GAFSSA), #419-424 (GLEPSI), 
#548-553 (GLDLSG), #562-567 (GAYVTD), and #627-632 
(GMREGA) . Potential cAMP- and cGMP-dependent protein 
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kinase phosphorylation sites could also be located at 
position #208-211 (KKRS) of all five BTV serotypes. Many 
more potential phosphorylation sites for casein kinase II 
phosphorylation, protein kinase C phosphorylation, and 
tyrosine kinase phosphorylation are found in VP4. However, 
NS2 is the only reported phosphorylated BTV viral protein 
(Devaney et al., 1988; Huismans et al., 1987). 
Two regions at residues #296-299 (DRLG) and #550-553 
(DLSG) of all five US BTV VP4 proteins have the DX2G 
sequence motif, which is conserved in all GTPase (Bourne et 
al., 1991). In the study of p21 ras , products of the ras 
oncogenes and proto-oncogenes, the asparate binds the 
catalytic Mg2+ through an intervening water molecule, 
whereas the amide proton of the glycine forms a hydrogen 
bond with the r-phosphate of GTP. These regions may be 
involved in the GTP-binding activity of VP4. 
A potential leucine-zipper motif located at positions 
#523-555 (LRVESSVLRVRNPTLHETADELRVRNPTLHETADELQRMGLDL) 
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contains a repeat of leucine residues at every seven th 
position (Fig. 5) and a short stretch of adjacent charged 
amlno acid residues. This is the first leucine-zipper 
motif reported in dsRNA viruses. This motif is predicted 
to form an amphipathic a-helix. An unusual cluster of 
prollne residues (5 out of 9) was also located about 10 
amino acids before this unique motif. A similar proline-
rich region was identified as a Src homology 3 (SH3) 
binding site of the SH3 binding protein (Ren et al., 1993). 
The proline-rich region of VP4 may serve a similar function 
as a protein-protein association module to facilitate 
binding to other viral proteins. 
The potential leucine-zipper motif of VP4 resembles 
that of many known transcriptional transactivators 
(Landschulz et al., 1988), which have a heptad repeat of 
five leucine residues and a basic region adjacent to the 
leucine repeats. Like jun, this region has uncharged 
residues at the fifth position of the repeat. It also has 
uncharged residues at every first and fifth positions, 
which have been reported to stabilize the zipper ln a 
coiled-coil helical conformation (O'Shea et al., 1989; Hu 
et al., 1990). The first and the fifth positions of this 
heptad are usually occupied by hydrophobic amino acids (the 
4-3 rule) (Zhou et al., 1992). Thus one side of the helix 
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lS predominantly hydrophobic. Another model of a coiled-
coil has symmetrical secondary hydrogen-bonding between the 
polar side chain of one helix and the peptide backbone of 
the opposite chain (Tropsha et al., 1991). Although helix-
breaking proline and glycine residues are found in this 
region of the VP4 leucine-zipper motif, a single glycine 
inserted by mutation did not abolish the function of yeast 
GCN4 protein, which is a DNA-binding protein with a 
leucine-zipper motif (Pu and Struhl, 1991). The T. 
thermophila isoleucyl-tRNA synthetase (ileRSs) has two 
leucine-zipper motifs in the carboxyl one third of the 
protein (Csank and Martindale, 1992) that are conserved ln 
the other ileRSs. Proline residues are also found in these 
motifs. In a recent report by Xia and Lai (1992), the 
hepatitis delta antigen (HDAg) with a leucine-zipper-like 
motif containing a proline residue is involved in the 
replication of HDV RNA. The results of this study 
demonstrated that the leucine-zipper motif is responsible 
for HDAg dimerization and the motif on the HDAg is 
indispensable for its activity in HDV RNA replication. 
Although the potential leucine-zipper motif found ln 
the BTV VP4 does not match all of the criteria of a DNA-
binding protein with a leucine zlpper motif (bZIP), VP4 
shares several features with proteins involved in RNA-
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~rotein i nteraction (Pu and Struhl, 1991; Xia and Lai, 
19 92). These RNA-bind i ng proteins have the potential to 
fo rm an amphipathic a -helix, in which a proline residue(s) 
i s found inside the heptad, and a basic region is located 
downstream of the motif. 
Recently, VP4 e xpressed 1n insect cells in a 
baculovirus expression system has been suggested as the 
guanylyltransferase involved with capping BTV mRNAs (Le 
Blois et al., 1992). However, this has not been definitely 
proven . The character i stics of VP4 suggest that VP4 might 
play an important role in BTV genome transcription and 
replication. The biological function(s) of VP4 is still 
unknown but the investigation of its potential function(s) 
is currently in progress. 
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Amino Acid Content of Deduced VP4 of the Five 
US Bluetongue Viruses 
BTV-2 BTV-10 BTV- 11 BTV-13 BTV-17 
Ala (A) 38 38 39 39 38 
Cys ( C) 4 5 5 5 5 
Asp (D) 46 49 48 48 48 
Glu (E) 45 45 46 46 45 
Phe (F) 24 25 25 2 4 25 
Gly (G) 34 34 33 33 33 
His (H) 26 25 25 24 25 
Ile (I) 40 37 37 38 39 
Lys ( K) 38 36 37 36 37 
Leu ( L) 62 62 62 62 60 
Met (M) 27 27 28 26 27 
Asn (N) 22 23 24 25 24 
Pro (P) 29 30 30 30 31 
Gln { Q) 9 8 8 9 8 
Arg ( R) 53 57 55 53 56 
Ser ( s) 41 36 36 37 38 
Thr (T) 20 23 22 22 22 
Val (V) 44 41 41 42 40 
Trp (W) 15 15 15 15 15 
Tyr ( Y) 27 28 28 30 28 
A+G 72 72 72 72 71 
S+T 61 59 58 59 60 
D+E 91 94 94 94 93 
D+E+N+Q 122 125 126 128 125 
H+K+R 117 118 117 113 118 
D+E+H+K+R 208 212 211 207 211 
I+L+M+V 173 167 168 168 166 
F+W+Y 66 68 68 69 68 
pi 7.82 7.58 7.43 7.06 7.76 
MW (kDa) 75.1 75.4 75.4 75.3 75.4 
TABLE 2 
Seque nce Identity Matrix of the M1 (Segment 4) Genes 
among the Five US Bluetongue Viruses 
Identity of sequences ( % ) 
BTV-2 BTV-10 BTV-11 BTV-13 BTV-17 
BTV-2 89.30 89.55 89.10 89.30 
BTV-10 97.36 98 ·. 69 98.44 98.49 
BTV-11 97.52 99.69 98.38 99.44 
BTV-13 96.74 98.91 99.07 98.13 
BTV-17 97.52 99.69 99.84 99.07 
63 
Note. Numbers above the diagonal indicate the percentage of 
identity of nucleotide sequences and numbers below the 




Number of Mismatches Between BTV Ml (Segment 4) Nucleotide 
Sequences Based on Codon Position 
Codon BTV-17 BTV13 BTV-11 BTV-2 
positions mismatches % mismatches %· mismatches % mismatches % 
BTV-10 
1st 4 <1 6 <1 4 <1 32 5 
2nd 2 <1 4 <1 2 <1 19 3 
3rd 26 4 22 4 21 4 161 25 
BTV-17 
4 <1 2 <1 32 5 
1st 
2 <1 0 0 16 2 
2nd 
32 5 8 2 165 23 
3rd 
BTV-13 
4 <1 34 5 
1st 
2 <1 18 2 
2nd 











Comparison of the Nucleotide ·Sequence Divergence Pattern of 
BTV M1 (Segment 4 ) Genes Based on Codon Positions 
Base Number of Number of true Extent of 
Serotype codon matched rnatchesa /% of related-
position nucleotides true rnatchesb nessc 
2 vs. 10 1 613/644 452/70 94 
2 629 468/72 97 
3 494 333/51 69 
17 
1 613/644 452/70 94 
2 vs. 
2 632 471/73 98 
3 495 334/52 69 
13 
1 611/644 450/70 93 
2 vs. 
2 630 469/73 97 
3 494 333/52 69 
1 614/644 453/70 94 
2 vs. 11 
2 630 469/73 97 




-11' -13, and 3 >93 
-17 
a. Number of matches mlnus the number of expected matches 
among random sequences which is 161 in M1 genes (25% of 
6 4 4) • 
b. Ratio of the number of true matches to the total number 
of nucleotides (percentage). A value of 75% and 0% 
represents complete identity and divergence, respectively. 









FIG. 1. Amplification a nd synthesis of full-length eDNA of 
M1 (segment 4) genes of five US BTV serotypes. Total 
genomic BTV dsRNA was mixed wi t h pr i mers (see text) 
complementary to the 3 ' -ends of M1 gene. The dsRNA was 
reverse transcribed into eDNA and then amplified by PCR. 
66 
Ten percent of the f inal product was analyzed by 1% agarose 
gel electrophoresis. Lane 1: 0.5 pg of BstE II digested 
lambda DNA marker; Lane 2: BTV-2; Lane 3: BTV-10; Lane 4: 
BTV-11; Lane 5: BTV-13; Lane 6: BTV-17; Lane 7: 0.3 pg BTV-
13 genomic dsRNA. 
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e:-;t J •.••••.••••••••••.••.••••....•••••.•...•••• ,_ •••••••••••.•..•.•.•••••••.•••.••..• 
B -;·;: 1 ' ' '' ' ' ' ' '• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • C • • • • • • • • • • • • • • • • • • • '• • • • • • • 
B: 'I 2 ' C ' ' • ' ' ' ' • C • ' • • • A· • • • • C • • T • • • • • • • • • • • • • • • • • .\ • • C • • • •;... • • • • • • A • • • • • • • • • • •;... • • ' ' • ' • • ' 
a -:'J ~ 7 ··· · ··A···················· · · · ··············· · ····· · ·· · ························· 
s : ·.· l J •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
e-:v 1 1 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • ••••••••••• • •• • •••••••••••••••••••••••••••••••• • ••• 
e:-v 2 ··A·· r ·· r ········;...···········r·················cc··· · c · · · .; · ccr············· ••••• 
B : v 10 A TTT C AC GCC TC CC AGGCGC . v-A CC :-7 GA.A CC .\ TC C A.AA TCCT CCCT'T ACA 7 ;:vv..A TT7.; T GC.V, TG CCGC A.AA T .\ CCG C ~ 9 0 
B -; ·: 1 1 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • C • • • • • • • • • • • • • • • • • • • • • • ' • ' ' ' ' ' ' • ' ' 
e 7 ·: ! 3 • • • · • • • • • ~ • • • • • • • • • · · · • • • • • · • • • • • • • • • • • • • • • • • • c • · • · · · · · c · · · · · · · · · · · · · · · · · · · · · · · · 
e:·.· : 1 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • · c · · · · · · · · · · · · · · · · · · · · · · · · · · • · c · · · · 
s-:- ·1 2 c· ·· · · · ········A···· ·c· ····A · ··············· ·.;••c• • · · · · · · · · · · · · · · · · · · · · · · · •c· · · · 
s -;•:: 0 C ATT .\ 7 AC A7G G A.A 7 AT CCGG NU7 ACCG ACT .l. C .>.TTT C.l.C C A7C ,; ccccA CTC .>. :-c;..;...,:v.c -:-7 ;.. GT ATCA.A 7 CC77 G.\ T 5 60 
s: ':~7 ·································· · ·············· r ······························ 
B 7 ·: 1 3 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • C • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
e:- ·; 1 1 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • ·r· • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
BT'J 2 • · c · · · · · · ·r· · · · · · · · · · · · · ·· · · · · · · · · · · · · · · · · · • · · • · ·r· · · · · · · · · · · · · · · · · · · · c · · · · · · · · · 
e-:-o.' l 7 • • • • • · • • • • • • • • c • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • · · • • 
8 : 'J 1 J ••••••••••••••••••••••••••••••••••• c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...... " ...... . 
8 T V 1 l " " " • " " • " • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • · • • • • • • " " • • " • " " " • • " 
B -:v 2 • ' ' ' ' ' ' ., • • • • • • C • • .\ • • G • • • • • A • • • • • • • • A • • • • • C • • • • • • • • • • • • • • • A • T • • • • • ' ' • ' ' • .\ ' ' ' ' ' 7 ' ' 
FIG. 2. Nucleotide sequence alignment of the M1 (segment 4) 
genes of five US bluetongue Vlruses. The initiation (ATG) 
and termination codons (TAA) are indicated by boxes. A 
total of 1981 nucleotides were found ln the M1 genes of 
BTV-2, -10, -11, -13, and -17. Asterisks represent 
nucleotides identical to those of BTV-10. Thymine (T) lS 
shown ln place of uracil presented ln the genomlc RNA. 
67 
BTV l O ACCAGCACCOTTTAC~CCOTCTTATGCCACGTATATGACCCAATAGCACCTGAGTGTTCAGATCCAAACGTTATACTTC 720 
BTV17 ••••••••••••••••••A•••••••••••••••••••••••••••••c•••••••••••••••••o••••••••••·•• 
BT'J ) • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
a:-v 11 • • • • • • • • ••• • • • • • • ·A·· • • • • • • • • • • • • • • • • • • • • • • • • • • •c• • • • • • • • • • • • • • • • •c• • • • • • •• • •• • • 
BTV 2 • * • • •• • • • • •••• • • • • • • •A.• • • • • • • • • • • • • • *C*T* • • • • • • • • • •c• •A•c• • • • • • • • • * • • • •• • * • • • * • • 
B ~VIO AT AATATTATGCTGCATTCAAAGAAAGACATTTTCAAACATATGAAIIIIIIGAAACGTCTTGAGACACTTTTCATATGC 800 
BT '/1 7 •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
BT \.' 1) • • • • •••••• •••• • ••••• • • • •• •• •• • • • •• ••••T••••••• • •• • •• • • • •• • • • '• • •• • • • •• • ••• •• •••• 
BTVll ••••••••••••••••••••••••••A••••••••••••••••••••••••••••••••••••••••••••••••••••• 
a TV 2 • • • • •c• • • • • • • • • • • • ,.. • • • • • • • • • • • • • • • • • • • • • • • • • • •c• • • • •A• • • • • • • .. • • ·A• ·c• •c• • • • • • • • • 
8 TV 10 GA TCTATCOTCAOATCGATCCCAGATGAA TGATCA'~'GAGTCCCAGACGACCAGCTTTGCGCAGCATACA TTGGQTCAGCA 8 8 0 
8TV17 •••••••••••••••••••••••••••••••••••••••••••••••A.•••••••••••••••••••••••••••••••• 
8TV 1) • • • * * • • • • •• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •A.• •A,• • • • • • • • • • • • • • • • * • • • • • • • • • • • • • • • 
8TVll •••••••••••••••••••••••• "••••••••••••••••••••••A.•••••••••••••••••••••••••••••••• 
B7V 2 • • • • •c••A.• •• • • • • •• • • • • • • • • •c· • • • ·a• • • •A• • • • ·AT• • • • • • •A• ·c· •A• • • • •• • •o• • •• •• • · • •• 




eTV 2 c• • • • ••• ••••••••• •c• • •••o• •c•• • • •••••• •• • •A••A• •T• • ••• •••A.••• • •••o•• ••••o•••• • •• 
BTVlO GCATTTCOACCTACTTATTCCCCCAACCCCGCGCCGATGCGCATATCTATOAATTAACCAATTTCATCACA7TCACACCT 1040 
!'TV l 7 • • • * • • • • • •T• • * • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
!Til)················································································ 
!TVll ••••••••••T••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
!TV 2 • • • • •• •• ••T•••c•Tc••• ••• •c;••••••••T••••• • ••• •• • • •c• • • •• ••• •••• •••••• •••• •••A•••• 




BTV 2 • • ••• ***T**A••••••••T•••••c•••••T••A•••••A•T••••••••••••o••••••••A•••••••••••••• 
8TVl0 ATTGTATCACOCTCGCOATCOTGGTAGATTTCTAAAAAAGAGACTATTTGAACACCTTCATATTCTACOTAAGAATCOAT 1200 
erv11 ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••o•••••A••••••• 
aTVlJ •• ••••••••••••••••••••••••c••••••••••••••••••••••••••••••••••••••••••••••••••••• 
!5'I"V l l •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
erv 2 • • • • • • • • •T•• • • • • • • • • • • • •c• · • • · •o•o• •o• •c• ·o• • • • • • • • • • • • • • · · · • • •c• •• • • • • • • • • • • •• • 
8TV10 TGTTACACOAAAOTGATOAGCCACGAGCGTATCTGTTTTATTTGACCAATCGCTGCAATATCGCATTGCAGCCTAGTArT 1280 
arv11 · · · • · •• • • • • • • • • • • • • • • • • • • • • • •c• • • • • • • • • • • • • • • • • • • • • • • • • • • •c•• • •• • •• • • • • • • • • • •• • • 
arv 1 J • • • • • • • • • • • • • • • • • • • • • • • • • • • • •c• • • • • • • • • • • • • • • • • • • • • • • • • • • •c• • • • • • • • • • • • • • • • • • • • • 
arv11 ··•••••••••••••••••••••••••••o••••••••••••••••••••••••••••c••••••••••••••••••••• 
BTV 2 • ·c•c••T•••••••••••A..•• ••• •• •.a.c••·•••• ••••• ••••• ••••••• ••••c••••••c••••A••A••c••• 
8TV10 TATCACGTAATGAA~AACTCGGTGATAGCTACTGCTTCGCTCGCCCGTCCGCCTTTATATGATTATOATCATTTCGCGTT lJ60 
!TV l 7 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •. •. •. • • • •••• •. • ••••• • • •. •. • • • •. • • • • • • • •• • 
arvll • ·c• ••••••••••••••••••••••• ••••••••••••••••• ••••• • ·••••••••••••••••••••••••••••• 
STVll •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
BTV 2 • • • **A* •• • •• • • • * • •• • • • • • • •c• • • • •A• •c• • • • •A• • • • • • • •T• • •c• • • • •• • • • • • • • • • • • • •• • • •• • 
BTVlO ACCCACATCTACCCTTATCCTCAACCCATCCTACCGCGATATCAGAATTCTAGATCCCAATGCCCCAATCCTATTCCTAA 1440 
BTV17 •••••••••••••••••••••••••••••••••••••••c•••••••••••••••••••••••••••••••••••••••• 
BTVl) • •••••••••••••••••••••••• •• ••••••• •• ••••• • •••T•• •• •• •• •••• ••••••••••••••••A••••• 
BT'/11 ····•••••••••••••••••••••••••••········c·············••••••••••••••••••••••••••• 
BTV 2 • • • • * • • • • * • *T* •c• ** * • * • •T• • • • •T• • • *AT• • • • • • • • • • • • • • • • • • • •r• • • * • * •••• * • • * •• *T* • • • 
BTVlO TGTCCACGTACCCCGATATCCTAAACAAAGATTTGACGTATCACCCTGCGTCGCCCATGAATTTTOCTGTTTCGCTAAAO 1520 
8TVl7 •••••••••••••A•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 




BTVlO C~GCCOATACCTGATCCTCCTCTCCCTC~T~TTTCTTTGTGT~GCTTCATCGCACTGCCCGTCGAATCATCCGTGCTGAO 1600 
8'TVl 7 • .,.,. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •• •• • • • • • • • • • • • • • • • • • ••c• • • • • • • • • • • • • • • • • 
B'f\' 1) •• • ••••• • ••• •• •• ••• ••••• ••••••••c• •• •••••••••••••••••••• ••••••T••••• •••••••••••• 
8T'I ll ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••T••••••••••••••••• 
BTV 2 • • • • • •• • • • •c• • • • •c• • • • • • • •c• • • • •c• •cc·A· •c••A• •T• • •• •• • •• • • •• •T• •c• • • • •T• • •T•• •• 
8TV10 GCTCCO~CCCAACATTACATG~CACGCCTGACOAACTCAAACGCATCGGATTGCATTTCTCTGGTCATTT~T~TGTCA 1680 
8TVli •••••••••T•••••••••••c••A•••••••••••••••••••••••••••••••••••••••••••••••••,~•••• 
!T'VlJ ••• •••••••••••••••••••••A•••••••••••••••••••••••••••••• ••••••••••••••••• •••• •••• 
B'I"Vll •••••••••T••••••••••••••A.••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
BT,/ 2 ••••••••••••••••••••••••A••••••••T•••••A.••••••••••••••••••••A,•••••••••c••••c•••• 
BTVl O CATT~TCTCCGGCGCTTATGTCACACATCTGTTTTGCTGCTTT~GATCATTCTAG~TTGGTCTCCCCAAAACAGCC~G 1760 
BTVlJ •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••A.•••A 
8 TV1J ••• ••• ••• •• • • •• •••••• •••••••••••••••••••••••••c••c•••••••••••• •••••• •••••••A•••A 
8TV ll •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••A•••A. 
e TV 2 • • • •c• • • • • • • • • • • • • • • • • • • • • • • •• • • • •c• • • • • • ••c• • • • • • • • • • •c• • • •• • • • • • • • • • • •a• •A• • • • 
BTVlO CAAAAACTACGCGATCTAAAG~GCTCTGCGCCGCAAGTAATTGACTGGAACCAGCACATCGCCCAGCCTCCATGCCATCT 1840 
~TV 17 •••••••••••••••••••••••••••••••••••o•••••••••••••••••••••••••••••••••••••••••••• 
8 TJ 1 ) • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
BTVll •••••••••••••••••••••••••••••••••••c•••••••• • ••••••••••••••••••••• • •• • •••••••••• 
BTV 1 • • • • • •T• * • *T* • *T* • • • • • • • • • • • •A• • • • •c• • • • •c• •A.• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •c• • • 
BTVlO GAGAAATCATCTCACTCGTGCGCT~GCCAAT~CAAACGCAAAATGCGC~TGAGACACGGACCCTCCATTCATTCGTGCC 1920 
BTV11 • •• •••••••••• •T••••• ••• • ••• •••••••••••••••••• •••••••••• •• • •••••••••• • •• •••• ••• • • 
8 1"\1 J • • • • • • • • • • • • • *T• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
BTVll ••••••••••••••T••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
B'T"V 2 •• • • •••A.G • ••A•T•GCA• • *T'G•••••c•••••*•••••••••• ••••A• •• • •• .. ••• ••• •• • •c• '•••••• • • 
BTV lO TAGAATTACTGCGTCACTT 
BT'/17 ••••••••••••••••••• 
l!rll J • •• ••••••••••••• • •• 
e rv11 ••••••••••••••••••• 
BTV 2 • • • • • • * • • • • • • • • • • • • 




lr-117 ••••••••••••••••••• ,., •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
IT"Ill •••••••••••• •••••••Jo('l•••• •• • •••• •••••••••••••••••••••••••••••••••••••••••••••••• 
IT"/ 11 • • • •••• • •• • •••• •• •• •r:• • • • • • • • • •• • • • • • ••••••• ••••••••••' •••••• ••••••••••••••••••• 
&TV 1 •• • •••••• • ••• ••• ••• ,. •• • • ·•· ••v· • ••v•••••••••••••• •••• •••• • • •••• •••••••••••t•• •• 
aT"J 1 1 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
&"T"V ll •••••••••••••············· ········ ··•••••••••••••••••••••••••••••••••v•••••••••• 
eT'\'Ll •••••••······························••••••••••••••••••••••••••••••••••••••w•••• 
eTV l • •• • • • •• • •••••(•Q• • •• • ••• • • • ••• • • • • •••• ••••n..••• • • •• •••• •••• ••• ••••••••••••w•• •• 
8-r"'/ l 7 •••••••••••••••••••••••••• • ••••••••••••••••••••••••••••••••••••••••••••••••••••• 
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3 . Alignment of the deduced amlno acid sequences 
the VP4 proteins of the five US bluetongue viruses. 
asterisks represent arnlno acids identical to those of 
10. A total of 644 arnlno acids were found ln the VP4 







potential leucine-zipper motif (#523-551) are indicated by 
arrows. 
71 
Nucleotide Amino Acid 
..------------ BTV 2 BTV 2 
BTV 13 BTV 13 
BTV 10 . BTV 10 
BTV 11 BTV 11 
BTV 17 BTV 17 
FIG. 4. Results of phylogenetic analysis of the five US BTV 
serotypes based on nucleotide and deduced amlno acid 
sequences of Ml (segment 4) genes. 
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FIG. 5. Helical wheel representation of the leucine repeat 
found in the pdtential leucine-zipper motif in the VP4 
proteins of five US bluetongue viruses. 
CHAPTER III 
DELINEATION OF THE ANTIGENIC DETERMINANTS AND 
SSRNA-BINDING DOMAINS OF THE MULTIMERIC 
BLUETONGUE VIRUS VP4 PROTEIN 
ABSTRACT 
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Heterologously expressed bluetongue Vlrus (BTV) lnner 
core protein VP4 was purified to near homogeneity. Six 
oligoclonal antibodies produced in rabbits were able to 
react with VP4 protein. These six linear epitopes of VP4 
were mapped to both termini and the middle of the protein. 
Enzyme-linked immunosorbent assay (ELISA) and peptide 
competition assay demonstrated that these slx linear 
epitopes are surface accessible. VP4 was shown to be a 
ssRNA-binding protein, and the leucine-zipper motif of VP4 
was not required for the RNA-binding activity. VP4 protein 
exhibited similar binding activity to both capped and non-
capped mRNAs. Its RNA-binding activity was not specific to 
BTV ssRNA since VP4 protein could bind to poly(U), and its 
BTV ssRNA-binding activity could be competed out in the 
presence of yeast tRNA in a reaction mixture. VP4 was also 
shown to be an oligomer by chemical cross-linking VP4 that 
was produced by in vitro translation. One RNA-binding 
domain was mapped by Northwestern assay and deletion mutant 
analyses between amlno acid residues #112-158. Using 
sequence sp~cific synthetic peptides corresponding to the 
arglnlne- and lysine-rich regions of VP4, four other 
potential ssRNA-binding domains of VP4 were identified. 
Althou gh BTV mRNA was assumed to be capped, I found that 
both capped and non-capped BTV mRNAs synthesized in vitro 
were translated with similar efficiency by a wheat germ 
extract in vitro translation system. 
INTRODUCTION 
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Bluetongue Vlrus (BTV), an agent that causes 
bluetongue disease ln domestic animals and wild ruminants, 
has been known for more than a century. It is classified 
in the Orbivirus genus of the family Reoviridae (Borden et 
al., 1971; Murphy et al., 1971). The icosahedral-shaped 
BTV has a double layered protein coat, and its genome is 
composed of 10 segmented dsRNAs (Verwoerd et al., 1972). 
There are two outer capsid proteins (VP2 and VP5) and five 
lnner capsid proteins (VP1, VP3, VP4, VP6, and VP7) in the 
double-l ~yer viral protein coat. 
The three minor inner core proteins (VP1, VP4, and 
VP6) were suggested to be the viral RNA-dependent RNA 
polymerase and the capping enzymes of BTV (Van Dijk and 
Huismans, 1980; Urakawa and Roy, 1989; Le Blois et al., 
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1992). Recombinant VP1 expressed ln insect cells had RNA-
dependent RNA polymerase activity ln the presence of 
poly(U) templates (Urakawa and Roy, 1989). VP6 has been 
shown to have nucleic acid binding activities, and its 
nucleic acid binding domains were identified by Hayama and 
Li (1994). However, the biological function(s) of VP6 lS 
still unknown. VP4 prepared from both purified virus and 
recombinant proteins has a GTP-binding activity (Le Blois 
et al., 1992). It is the prime capdidate for being the 
guanylyltransferase of BTV. However, the capping activity 
of VP4 has never been proven. 
The M1 genes coding for the VP4 proteins of five US 
BTV serotypes were cloned and sequenced (Chapter II). The 
sequences of all five VP4 proeins have a very high degree 
of homology (96-99%) and conserved hydrophilic and 
hydrophobic regions, determined from hydropathy plot 
analyses. From the deduced amino acid sequences of VP4, a 
unique leucine-zipper motif and several basic amino acid 
clusters were found in this protein. These motifs are 
found in many nucleic acid binding proteins (Perutz, 1992). 
Whether VP4 is a nucleic acid binding protein is unknown. 
In this study, I intend to characterize the structure 
of VP4 as well as to investigate the function(s) of VP4. 
Using recombinant VP4 proteins, VP4 was shown as an RNA-
binding protein and its structure was characterized. 
MATERIALS AND METHODS 
Construction of recombinant 
plasmids 
The full-length BTV-13 M1 gene in the plasmid 
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pUC19BTV13M1 (Chapter II) was subcloned into the Pst I site 
of a baculovirus expression vector pVL1392 (Invitrogen). 
The pUC19BTV13M1 plasmid was digested with Pst I and 
resolved on a 1% low-melting agarose gel. After 
electrophoresis, the band corresponding to the size of M1 
gene was excised from the gel, the gel slice was melted and 
ligated to Pst I-digested and CIP-treated pVL1392 
expresslon vector, as described in Chapter II. The 
orientation of the recombinant plasmid carrying BTV-13 M1 
gene was confirmed by BamH I restriction enzyme digestion. 
The recombinant plasmid for transfection into insect cells 
was purified according to Kraft et al. (1988) and further 
purified by polyethylene glycol (PEG) precipitation. To 
produce BTV-13 M1 mRNA for in vitro transcription and 
translation, the BTV-13 M1 gene was cloned into pGEM4Z 
(pGEM4ZBTV13M1) using the same procedures. A mutant, ln 
which the leucine-zipper region was deleted, was 
77 
constructed by digesting pGEM4ZBTV13M1 with Xba I. This 
enzyme cut at nucleotide positions #1409 and #1734 inside 
the BTV-13 M1 eDNA, and at nucleotide #34 inside the pGEM4Z 
vector. After digestion, the reaction mixture was resolved 
on a 1% low-melting point agarose gel. Two fragments 
without the leucine-zipper coding reg1on (1.4 kb and 3 kb) 
were excised from the gel and ligated to each other. The 
orientation of the insert was checked by Kpn I restriction 
enzyme digestion. This leucine-zipper deleted mutant had 
an internal deletion between bases #1409-1733 (amino acid 
residues #468-575), and was in-frame to the C-terminal 
coding region. 
Construction of recombinant 
plasmids and 3'-deletion 
mutants for express~on 
~n E. coli 
The full-length eDNA of the BTV-13 M1 gene was 
amplified from the dsRNA genome of BTV according to the 
. 
method described in Chapter II. A pair of primers 
containing the sequences of 5'-GACGTCGACCCGGGGATGCCTGAGCCA 
-3'and 5'-GACGTCGACCCGGGTAAGTTGTACAT-3' (the sequences of 
the BTV M1 gene are underlined) was used for amplification, 
and the eDNA was cloned into the pTrxFus (Invitrogen) 
expression vector at the Sma I site. This enzyme removed 
the 5' non-coding reg1on (eight bases), and fused the 
remalnl n g M1 eDNA in-frame to the reglon coding for 
thio redoxin. In this expression system, the target 
proteins are expressed as thioredoxin (Trx) fusio~ 
proteins. The recombinant plasmids were transformed into 
E. coli GI698 or GI724 (Invitrogen) by electroporation 
(Gene Pulser™, Bio-Rad, settings of 25 pF, 2.5 kV, 200 Q, 
4 msec) . The orientation of the insert was determined by 
BamH I enzyme digestion. 
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The pTrxBTV13 plasmid was used for constructing the 3' 
deletion mutants of the M1 gene with the Erase-A-Base kit 
(Promega). Because exonuclease III (Exo III) will digest 
the nicked DNA, supercoiled plasmids are required to 
construct deletion mutants. To purify supercoiled 
plasmids, acidic phenol extraction was used. An overnight 
E. coli culture (200 ml) was centrifuged at 2000x g for 10 
mln. The E. coli pellet was resuspended ln 10 ml of lysis 
buffer (25 rnM Tris-HCl, pH 8, 50 mM glucose, 10 mM EDTA, 5 
mg/ml lysozyme) and incubated at room temperature for 5 
min. A total of 20 ml 0.2 N NaOH and 1% SDS mixture was 
then added to the solution and incubated on lee. After 10 
min incubation, 12.5 ml of saturated ammonium acetate was 
added to the solution, and gently mixed for 30 sec, 
followed by an additional 10 min incubation on 1ce. The 
solution was then centrifuged at 12,000x g for 10 min at 
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4° c. The supernatant was passed through a glass-wool 
plugged fun~el into a centrifuge bottle. Seven-tenths 
volume of ice-cold isopropanol was added to the filtrate, 
mixed, and kept on ice for 20 min. DNA was recovered by 
centrifugation at 12,000x g for 15 min at 4° C. The DNA 
pellet was then dissolved 1n 6 ml of acidic extraction 
solution (0.75 M NaCl, 10 mM EDTA, 0.3 M sodium acetate, pH 
4.2), and kept on ice for 5 min. An equal volume of water-
saturated phenol was added to the DNA solution, vortexed 
for 1 min, and centrifuged at 12,000x g for 10 min at 4° C. 
The top layer was discarded and the acidic extraction was 
. 
repeated once. The organic phase was then mixed with 3.5 
ml of reverse extraction buffer (1.5 M Tris-base, 5 mM 
EDTA) and 3.5 ml of chloroform. After centrifugation, the 
top layer containing the supercoiled plasmids was removed 
to a new tube and extracted once with an equal volume of 
chloroform. The supercoiled plasmids were then 
precipitated by addition of 0.1x volume of 3 M sodium 
acetate, pH 4.2, and 0.7x volume of ice-cold isopropanol. 
The plasmids were recovered by centrifugation at 4,000 rpm 
for 15 min at 4° C and washed twice with 70% ice-cold 
ethanol. The super-coiled plasmid DNA pellet was then 
dried and dissolved in TE. 
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To construct the deletion mutants, the supercoiled 
plasmids were digested with Pst I and Nco I restriction 
enzymes to create an Exo III (Promega) resistant 3'-
overhang end (within the expression vector) and a 5'-
unprotected end (3'-end of the M1 gene) in the linearized 
plasmids. The linearized plasmids were analyzed by gel 
electrophoresis to confirm that digestion was completed, 
then purified by phenol/chloroform extraction as described 
in Chapter II. The linearized plasmids (5 pg) were 
dissolved ln 60 pl of Exo III buffer (66 mM Tris-HCl, pH 
8.0, 0.66 mM MgCl 2) and then digested with 300 units of Exo 
III at 15° C. At every 30-sec interval, 2.5 pl of the 
reaction mixture were transferred to a tube containing 7.5 
pl of S1 nuclease mixture (2 units S1 nuclease, 40 mM 
potassium acetate, pH 4.6, 333 mM NaCl, 1.25 mM ZnS04 , 
6.75% glycerol) and kept on ice to stop the Exo III 
digestion. At the end of sample collection, the DNA 
samples were incubated at room temperature for 30 min to 
start the S1 nuclease digestion, to remove the single-
stranded tails left after the Exo III digestion. One pl of 
S1 nuclease stop buffer (0.3 M Tris base, pH 10, 0.05 M 
EDTA) was added, followed by heating at 70° C for 10 min to 
inactivate the S1 nuclease. One pl of Klenow mixture (100 
u/ml of Klenow DNA polymerase, 20 mM Tris-HCl, pH 8.0, 100 
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mM MgCl 2) was added to the reaction mixture and incubated 
for 5 min at 37° C, before 1 pl of dNTP mixture (0.125 mM 
each of dATP, dCTP, dTTP, dGTP) was added to generate blunt 
ends for ligation. The ligation mixtures were then used to 
transform E. coli strains GI698 and GI724, and the 
transformed E. coli was selected on agar plates with 
ampicillin. The deletions were confirmed by DNA sequenclng, 
and expression of the truncated proteins was confirmed by 
immunodetection with antibodies. 
Expression and purification of 
VP4 in the recombinant 
baculovirus system 
Insect cells were grown and maintained as described by 
Johnson and Li (1991). Co-transfection with the 
recombinant pVL1392BTV13M1 plasmid and linear baculoviral 
DNA (Baculogold™) was performed according to the 
manufacturer's protocol (PharMingen). A monolayer of SF-9 
cells grown in Grace's medium with 10% fetal bovine serum 
or High-S™ cells grown in serum-free Excel 405 medium 
(J.R. Scientific) at 80% confluence were infected with 
recombinant baculovirus carrying the BTV-13 M1 gene at a 
multiplicity of infection (M.O.I.) of 10 to 20. After 72 
hr postinfection, the insect cells were centrifuged 
(Beckman GPR Centrifuge) at 1,000 rpm for 10 min, and the 
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cell pellets were washed with phosphate-buffered saline 
(PBS). The cell pellets were resuspended in STE (10 mM 
Tris-HCl, pH 8, 1 mM EDTA, and 150 mM NaCl) and lysed by 
sonication (VirSonic, 80% power output) three times (10 sec 
each) at 0° C. Recombinant VP4 was identified by comparing 
the cell lysate to mock-infected cells with both SDS-PAGE 
and immunodetection. VP4 was found mainly in insoluble 
form due to aggregation. The insoluble VP4 was pelleted by 
centrifugation at 4,000 rpm for 15 min at 4° C. Because of 
the high yield of VP4, a major portion of the pellets was 
composed of VP4. Insoluble VP4 was dissolved at a final 
concentration of 0.3 mg/ml in STE containing 5 mM 
dithiothreitol (DTT), 0.15% N-lauroyl sarcosine, and 0.01 % 
Triton X- 100 (TX- 100). After 30 min of incubation at room 
temperature, insoluble materials were removed by 
centrifugation at 4,000 rpm for 30 min. The soluble VP4 ln 
the supernatant was then dialyzed against STE with 0.05 % N-
lauroyl sarcosine, 0.01% TX-100, and 10 mM reduced 
glutathione for 5 hr at 4° C. The dialysis buffer was then 
changed to STE with 0.01% TX-100 and 5 mM reduced 
glutathione and dialyzed overnight at 4° C. The dialyzed 
protein solution was then centrifuged at 4,000 rpm for 30 
min at 4° C to remove any aggregated protein. The 
dialysate was passed once through a Sephadex G-75 
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(Pharmacia) sizing column pre-equilibrated with STE. The 
soluble VP4 was found in the void volume and the low 
molecular weight cellular proteins were retained in the 
column. VP4 was further purified through a 5 to 50% (w/v) 
discontinuous sucrose gradient with a cushion of 66% 
sucrose (w/w) in STE. After centrifugation at 30,000 rpm 
(Beckman LS-70 Ultracentrifuge) for 1.5 hr at 4° C in a 
SW41 rotor, VP4 was located at the interface of the 50% and 
66 % sucrose solution. 
Expression of VP4 in E. coli 
The full-length and 3'-end deleted Ml genes cloned 
into the expression vector pTrxFus were transformed into E. 
coli strain GI698 or GI724 by electroporation as previously 
described. The expression procedures from the manufacturer 
(Invitrogen) were followed. An overnight culture of E.coli 
in RM medium (1x M9 salt, 2% casamino acid, 1% glycerol, 
1mM MgC1 2 , 100 pg/ml ampicillin) was grown at 30° C and 
diluted 20-fold with the induction medium (1x M9 salt, 0.2% 
casamino acid, 0.5% sucrose, 1rnM MgCl 2, 100 pg/ml 
· ampicillin). After 2.5 hr of shaking at 30° C, tryptophan 
was added to the culture at a final concentration of 100 
~g/ml as an inducer. The temperatures for VP4 expression 
in E. coli GI698 and GI724 were 30° C and 37° C, 
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respectively. At 3.5 hr postinduction, the E. coli cells 
were harvested, lysed, and analyzed by gel electrophoresis 
and by immunodetection. 
Production of oligoclonal and 
monoclonal antibodies 
The locations of potential antigenic epitopes of VP4 
were predicted using the PlotStructure Program in the GCG 
software (Genetic Computer Group, 1994). Six synthetic 
peptides synthesized in the multiple antigen peptide format 
were used as immunogens to produce oligoclonal antibodies 
(OAbs) against VP4 (Li and Yang, 1990; Yang et al., 1992; 
Huang et al., 1995). The positions of these six peptides 
were residues: #617-626 (RALREYKRKM), #583-592 
(KEQKLRDLKR), #167-178 (GARFDDEPTDEK), #376-385 
(RDRGTFLKKR), #103-115 (ENEIGRRRIRMRK), and #523-551 
(RVESSVLRVRNPTLHETADELKRMGLDL) . The corresponding OAbs are 
designated as OAb #76, 77, 78, 80, 81, and 82, 
respectively. Rabbits were immunized intramuscularly with 
0.5 ml of the peptide solution (100 pg of each individual 
peptide resuspended in PBS) mixed with an equal volume of 
Complete Freund's Adjuvant (Sigma). Booster injections 
followed every 3 weeks with a mixture of antigen and 
Incomplete Freund's Adjuvant (Sigma). Between each booster 
injection, 10 ml of sera were collected from the rabbits 
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for analysis of the antibody titers. After the fourth 
booster, rabbits were bled, and the antisera were collected 
and pooled for immunodetections. Recombinant VP4 expressed 
in insect cells was used os an antigen to produce anti-VP4 
monoclonal antibodies (MAbs) by the Biotechnology Center at 
Utah State University. The anti-VP4 MAbs (D3.6.24 and 
D3.10.1) were determined to be the IgM isotype. 
Enzyme-linked immunosorbent 
assay (ELISA) 
ELISA us1ng OAbs and MAbs was carried out as described 
by Yang et al. (1992) with some modifications. Purified 
VP4 proeins (5 pg) in 50 pl of 10 mM sodium carbonate, pH 
9.6, were immobilized overnight at 4° C to the bottom of a 
96-well plate (Dynatech) . The plate was washed six times 
with PBS containing 0.05% Tween-20 (Sigma) (PBS-T), and 
blocked with 200 pl of 3% bovine serum albumin (BSA) in 
PBS-T for 1 hr at 37° C. The plate was washed with PBS-T 
aga1n before antibodies were added to the wells. The 
antibodies were diluted at 1:10, 1:100; 1:1,000, and 
1:10,000 in PBS-T for the assay. After 90 min of 
incubation at room temperature, the plate was washed four 
times with PBS-T to remove the unbound antibodies. Second 
antibodies (alkaline phosphatase(AP)-conjugated goat anti-
rabbit IgG or AP-conjugated goat anti-mouse IgM antibodies) 
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were added to the wells at 1:10,000 dilution and incubated 
at 37° C for 1 hr. The plata was then washed with PES-T 4 
times and another four times with AP developing buffer (100 
mM Tris-HCl, pH 9.5, 5 mM MgC1 2 , 100 mM NaCl). The color 
reaction was developed with the addition of AP substrate, 
p-nitrophenyl phosphate, disodium (pNPP) (Sigma) in the AP 
developing buffer mixture. The extent of binding was 
measured in triplicate at 405 nm by an ELISA reader 
(Dynatech) . 
SDS-PAGE and immunodetection 
The protocols used for SDS-PAGE and immunodetection 
were similar to those routinely employed in our laboratory. 
Briefly, proteins were separated on a discontinuous SDS-
PAGE using the method of Laemmli (1970) and transferred to 
two nitrocellulose membranes by a diffusional sandwich 
technique, in buffer containing 25 mM Tris-HCl, 192 mM 
glycine, and 20% (v/v) methanol. The epitope analyses by 
immunodetection were carried out as previously described by 
Li and Yang (1990). 
Immunoblocking assay by 
synthetic peptides 
Each of the synthetic peptides (50 ~g) dissolved in 
PBS was mixed with 20 pl of ascites fluid and incubated for 
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2 hr with constant agitation at 37 ° C. The MAb incubated 
with PBS only (without any peptide) was used as a positive 
control. After a brief centrifugation, the cross-absorbed 
MAbs in the supernatant were used for immunodetection 
(1:400 dilution) against recombinant VP4 in SF-9 cell 
lysate in Western blot analyses. The loss of reactivity 
with VP4 indicated the possible location of the epitope. 
In vitro transcription and 
translation of mRNA 
of Ml gene 
The pGEM4Z vectors carry1ng the full-length BTV-13 M1 
gene or the leucine-zipper deleted mutant were linearized 
with Sma I, and RNA transcripts were synthesized using T7 
RNA polymerase. The reactions were carried out in the 
presence or absence of an RNA-cap analog (BRL) . For making 
non-capped mRNA, 6 pg of linearalized plasmids were 
incubated in a final volume of 100 pl reaction mixture 
containing 40 mM Tris-HCl, pH 7.5, 6 mM MgCl 2, 2 mM 
spermidine, 10 mM NaCl, 0.5 mM of each rNTP, and 50 units 
of T7 RNA polymerase at 40° C for 1.5 hr. For making 
capped mRNA, 0.5 mM of RNA cap analog (BRL) and 0.05 mM 
rGTP were used to replace the 0.5 mM rGTP in the reaction 
mixture. The synthesized mRNA should have more than 90% 
capped mRNA using the in vitro transcription kit with RNA 
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cap analog (BRL), according to the manufacturer. At the end 
of the reaction, the DNA templates were digested with DNase 
(BMB) and the RNA transcripts were extracted with phenol-
chloroform and precipitated with ethanol. An amount of 
transcript (0.3 pg) dissolved in H20 was used for in vitro 
translation with 25 pl of wheat germ extract (Promega), 4 
pl of 1mM amino acids mixture (without methionine) 
(Promega), 1 pl of RNase inhibitor (100u/pl) (USB), and 2.5 
pl of [ 35S]-methionine (10 mCi/ml) (Amersham) in a 50-pl 
reaction mixture, at 25° C for 2 hr. Before mixing the 
mRNA with the translation mixture, the template mRNA was 
heated at 67° C for 10 min and chilled on ice immediately 
to destroy local regions of secondary structure. The 
amount of rnRNA used for in vitro translation was optimized 
and found to be 0.06 pg per 10 pl of reaction. The 
translation mixtures were centrifuged for 5 min at 4° C ln 
a microcentrifuge before subsequent analyses. 
Poly(U)-Sepharose 4B affinity 
chromatography 
Ten pl of the in vitro translated intact or truncated 
VP4 proteins were diluted with 200 pl of TE (10 mM Tris-
HCl, pH 8, 1 mM EDTA) and applied onto a 0.6 ml poly(U)-
Sepharose 4B column (Sigma) pre-equilibrated with TE. The 
column was then washed with TE until no radioactivity was 
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detected ln the flow-through fractions, monitored with a GM 
counter. The bound VP4 proteins were eluted with a step 
gradient of 0.15 , 0.5, and 1.5 M NaCl in TE (pH 8). The 
eluants were precipitated by 10% trichloroacetic acid 
(TCA), with 10 pg of bovine serum albumin (BSA) as a 
carrier, at 0° C for 20 min. After centrifugation at 
10,000x g for 10 min, the pellets were washed with 70% 
ethanol or acetone and dried at 37° C. The pellets were 
dissolved in 15 pl of SDS-PAGE sample buffer and boiled for 
3 min before SDS-PAGE analysis. Pre-stained protein 
markers were used as molecular weight references. At the 
end of electrophoresis, the gels were dried under vacuum at 
80° C and exposed to X-ray film for autoradiography. 
RNA probes preparation 
Both capped and non-capped [3 2P]-labeled BTV M1 ssRNAs 
were in vitro transcribed as described above except that 
[a- 32 P]-rGTP (15 pCi/ml) was included in the reaction 
mixture. Nonradioactive RNA probes were labeled with 
biotin (BRL) . 
Electrophoretic mobility 
shift assay (EMSA) 
Secondary structures of the ssRNA were initially 
disrupted by incubating at 70° C for 10 min and chilling on 
90 
lee immediately. Various amounts of purified VP4 ln STE 
were incubated with 28 ng of [32 P]-ssRNA at room 
temperature (about 22° C) for 20 min in a reaction buffer 
containing 10 1nM Tris-HCl, pH 8, 1 mM EDTA, and 60 mM NaCl. 
The protein-RNA complexes were resolved on a 0.8% agarose 
gel (0.5x TEE buffer) at 100 V until the bromophenol blue 
dye front reached the bottom of the agarose gel. The gels 
were fixed with 10% methanol and 10% acetic acid for 15 mln 
and dried between two sheets of BioGel wrap membranes 
(BioDesign) at 37° C prior to autoradiography. 
Northwestern Assay 
Various amounts of sequence-specific peptides were 
dot-blotted to a nitrocellulose membrane. The membrane was 
then washed with 0.1x STE buffer and incubated with [ 32 P]-
ssRNA for 30 mln. The membrane was washed with the same 
buffer three times (10 min each), air dried, and used for 
autoradiography. 
To develop the Northwestern assay using a biotinylated 
RNA probe, the nitrocellulose membrane was first blocked 
· with 3% BSA in binding buffer for 1 hr, followed by adding 
the RNA probes to the binding solution and incubating for 
30 min. The bound RNA probes were detected with avidin-
conjugated horseradish peroxidase (HRP) . The color 
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reaction was developed in 10 ml of developing solution (0.6 
mg/ml o f diaminobendizine ln 9 mM Tris-HCl, 0.03 % CoCl 2, 
For the mapping of RNA-binding domain uslng truncated 
Trx-VP4 fusion proteins, proteins were separated on SDS-
PAGE and transferred overnight at room temperature in 
transfer buffer (25 mM Tris-HCl, pH 8.3, 192 mM glycine, 
20 % methanol) to nitrocellulose membranes (Li and Yang, 
1990 ) . The proteins were allowed to "renature" by washing 
membranes in binding buffer (10 mM Tris-HCl, pH 8, 50 mM 
NaCl, 1 mM EDTA, and 1x Denhardt's solution) at room 
temperature for at least 1 hr with three changes of buffer. 
[
32 P] -labeled RNA probes were added to 10 ml binding buffer 
and incubated with the nitrocellulose membrane containing 
the transferred proteins at room temperature for 1 hr. The 
membrane was then washed with binding buffer three times 
for 5 min each. The membrane was then air dried and 
exposed to X-ray film for autoradiography. 
Chemical cross-linking of 
VP4 protein 
In vitro translated VP4 proteins (3 pl) were diluted 
with 87 pl of cross-linking buffer (20 mM HEPES, pH 8, 150 
mM NaCl, 1 mM EDTA) to a final volume of 90 pl. Cross-
linking was initiated by the addition of 10 pl of 0.1% 
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glutara l dehyde (50% EM grade, Sigma). At predetermined 
times of incubation at room temperature, the cross-linking 
reactions were terminated with the addition of 100 pl of 
1 M glycine. Proteins were precipitated with TCA (10%) at 
0° c for 20 min with 10 pg of BSA as a carrier. 
Precipitants were washed with cold acetone were resuspended 
in SDS-PAGE sample buffer, then resolved on a 3.5% SDS-PAGE 
(1.5 rom thickness) gel prepared according to Sigma 
Technical Bulletin (MWS-877). Proteins were separated by 
electrophoresis at 50 rnA (room temperature) for 13 hr. At 
the end of electrophoresis, the gel was stained by 
Coomassie blue and destained to visualize and locate the 
molecular weight markers. The gel was then dried under 
vacuum (80° C) and used for autoradiography. Cros~-linked 
phosphorylase b proteins (Sigma) were used as molecular 
weight markers. 
RESULTS 
Production and purification 
of recombinant VP4 
~n insect cells 
SF-9 or High-5 cells infected with recombinant 
baculovirus carrying the BTV-13 M1 gene expressed high 
levels of VP4. The recombinant VP4 had a molecular weight 
close to 75 kDa as determined by SDS-PAGE. This molecular 
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weight is similar to that predicted from the deduced am1no 
acid sequence (Huang et al., 1993) and to the VP4 in 
purified BTV virions. The level of VP4 expression was 
M.O.I.-dependent (Lane 1 and 2, Fig. 6A). The identity of 
the expressed VP4 was confirmed on a Western blot by 
immunodetection using a polyclonal antibody against BTV 
virions (Fig. 6B and C). The bulk of recombinant VP4 
expressed in insect cells was insoluble even though VP4 has 
a high content of charged and polar amino acid residues 
(Huang et al., 1993). This was also true when VP4 was 
expressed as thioredoxin (Trx)-VP4 (Invitrogen), 
glutathione-S-transferase (GST)-VP4 (Pharmicia), and six 
histidines (6xH)-VP4 (Qiagen) fusion proteins in different 
strains of E. coli and under different induction conditions 
(data not shown). Many conditions were employed in the 
attempt to purify a large quantity of VP4 for structure and 
function analyses. Unfortunately, no method worked to 
produce soluble VP4. These methods, which are summarized 
in Appendix D, have been tried and investigated without 
success. However, the insoluble VP4 was solubilized 
successfully upon treatment with STE buffer containing 
0.15% N-lauroyl sarcos1ne, 5mM DTT, and 0.01% TX-100. The 
detergents were removed by stepwise dialysis, which allowed 
the VP4 protein to be maintained in its soluble form. The 
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optimal VP4 concentration for refolding and renaturation 
was 0.3 mg/ml. Concentrations higher than 0.3 mg/ml 
resulted in rapid precipitation to an insoluble form. VP4 
was further purified to near homogeneity by a sizing column 
and sucrose gradient (Fig. 7). Because VP4 formed an octa-
meric structure at a molecular weight of 600 kDa (see 
below), the VP4 oligomer was in the void volume during 
elution from the Sephadex G-75 sizing column. The VP4 
oligomers could be separated from other proteins by discon-
tinuous sucrose gradients. The VP4 oligomers were found at 
the interface of 50% (w/v) and 66% (w/w) sucrose solutions 
after ultra-centrifugation at 110,000x g for 1.5 hr. 
Identification of the antigenic 
epitopes of VP4 
To identify and map the linear antigenic epitopes of 
VP4, potential antigenic epitopes of the cognate VP4 were 
predicted by the GCG computer package. Six oligopeptides 
were synthesized in the multiple antigen peptide (MAP) 
format (Tam, 1988; Li and Yang, 1990; Yang et al., 1992 
Huang et al., 1995) and then used to produce six OAbs (OAb 
#76, 77, 78, 80, 81, and 82) in rabbits. The OAbs were 
analyzed by immunodetection on Western blots (Fig. 8) and 
ELISA (Fig. 9). In Western blot immunodetection as shown 
in Fig. 8, OAb #78, 81, and 82 reacted well with VP4 at 
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1:1,000 dilution; OAb #80 had a moderate reactivity at 
1:500 dilution; OAb #76 and 77 had a very limited 
reactivity even at 1:250 dilution. These results are 
evidence that amino acid residues between #617-626 (RALREYK 
RKM), #583-592 (KEQKLRDLKR), #167-178 (GARFDDEPTDEK), #376-
385 (RDRGTFLKKR), #103-115 (ENEIGRRRIRMRK), and #523-551 
(RVESSVLRVRNPTLHETADELKRMGLDL) represent linear epitopes or 
major linear components of conformational epitopes of VP4. 
To determine whether these antigenic epitopes are 
surface accessible, an ELISA was carried out using these 
six OAbs against purified VP4 (Fig. 9). In ELISA tests, 
OAbs #76, 78, 81, and 82 had strong reactions with the 
native and intact VP4, and OAb #77 and 80 had weaker 
reactivities. These results are evidence that the 
antigenic domains corresponding to the sequences of 
peptides #76, 77, 78, 80, 81, and 82 are potential linear 
epitopes on the surface of VP4. OAb #76 had a very weak 
reactivity against the denatured VP4 on a Western blot 
(Fig. 8), but had a strong reactivity against native VP4 1n 
ELISA (Fig. 9). This implied that the conformation of this 
region is important for the reaction with OAb #76. 
Monoclonal antibodies against VP4 (D3.6.24 and 
D3.10.1) were produced for an attempt to map conformational 
epitopes (Fig. 9 and 10). To identify the location of 
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these conformational epitopes, an epitope-scanning approach 
(Hwang and Li, 1993) with sequence-specific synthetic 
peptides was used to block binding of MAbs towards VP4 on a 
Western blot (Fig. 10). The two MAbs in ascites fluid were 
incubated with 50 pg of each synthetic peptide (#76, 77, 
78, 80, and 81) individually at 37° C for 2 hr with 
constant agitation. The cross-absorbed ascites fluids were 
then used for immunodetection on a Western blot (Fig. 10). 
As shown in Fig. lOA, peptides #76, 80, and 81 blocked the 
binding of MAb D3.6.24 to VP4. Since the locations of 
peptides #76 (residues #617-626), #80 (residues #376-385), 
. 
and #81 (residues #103-115) are located in different 
reglons of VP4, this suggests that the antigenic epitope 
defined by MAb D3.6.24 is a conformational determinant. As 
shown in Fig. lOB, only peptides #76 (residues #617-626), 
and #81 (residues #103-115) blocked the binding of MAb 
D3.10.1 to VP4. These results are evidence that the 
epitope recognized by MAb D3.10.1 is conformational and 
were also consistent with the results of ELISA that 
peptides #76, 80, and 81 are surface accessible. 
Nucleic acid binding 
activity of VP4 
VP4, a GTP-binding protein, lS a candidate for being 
the guanylyltransferase of BTV (Le Blois et al., 1992). A 
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potential leucine-zipper motif and a stretch of charged 
amino acid residues upstream of the zipper region were 
identified from the deduced amino acid sequences of five US 
BTV VP4 proteins (Huang et al., 1993). These features are 
found in many nucleic acid binding proteins. The proposed 
guanylyltransferase activity of VP4 suggested that this 
protein may be a ssRNA-binding protein. Therefore, the 
ssRNA-binding activity of VP4 was investigated. 
As shown in Fig. 11A, the binding of VP4 to the BTV 
ssRNA resulted in retardation of the migration of the 
labeled RNA transcripts in gel electrophoresis. The amount 
of RNA retarded in EMSA was proportional to the amount of 
VP4 added to the reaction mixture. When non-labeled, non-
capped RNA transcripts were added to the RNA-binding 
reaction mixture, the amount of labeled, retarded RNA 
transcripts was inversely proportional to the amount of 
added non-labeled RNA. This is evidence that the binding 
of VP4 to ssRNA was not dependent on the cap structure of 
the transcript (Fig. 11B). The specificity of VP4 ssRNA-
binding activity was also determined by competition with 
unlabeled yeast tRNA. As shown in Fig. 12, the labeled 
ssRNA transcripts were not retarded · when 500 pg of 
unlabeled yeast tRNA was added to the reaction mixture. 
Upon the addition of 1% SDS to the reaction mixture, VP4 
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aborted the RNA-binding activity (Lane 5, Fig. 12). This 
is evidence that the nondenatured form of VP4 is required 
for RNA-binding. The identity of RNA was confirmed by 
incubating the RNA with RNase A in 60 mM NaCl. The ssRNA 
was digested by this nuclease treatment (Lane 6, Fig. 12). 
Because the leucine-zipper motif is involved in 
nucleic acid binding activity of some proteins (Perutz, 
1992), the role of the VP4 leucine-zipper motif in the RNA-
binding activity was investigated. The intact and the 
truncated VP4 (VP4~LZ), which has an internal deletion of 
the leucine-zipper region, were translated in vitro (Fig. 
13B), and their RNA-binding activity toward poly(U)-
sepharose was tested. 
In vitro translated VP4 was able to bind to poly(U)-
sepharose (Fig. 3A). VP4 was eluted with 0.15 M NaCl in TE 
at pH 8. The deletion mutant without the leucine-zipper 
motif was also able to bind to the poly(U) in the sepharose 
column (Fig. 14B). These results are evidence that the 
leucine-zipper motif within the VP4 protein is not required 
for the RNA-binding activity. 
Mapping the ssRNA-binding 
domains of VP4 
To locate the RNA-binding domain of VP4, a series of 
C-terminus deleted VP4 proteins were constructed by 
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deleting the 3'-end of the Ml gene ln the pTrxVP4 plasmid 
(see MATERIALS AND METHODS). These C-terminal truncated 
VP4 proteins were expressed as thioredoxin (Trx) fusion 
proteins. Trx-VP4 and most of the tr~ncated Trx-VP4 
mutants were expressed as an insoluble form. Nucleic acid 
binding on protein blots has been used to identify DNA-
(Bowne et al., 1980; Hoch, 1982) and RNA- (McCormack et 
al., 1992; Labbe et al., 1994) binding proteins. Since it 
is difficult to purify the insoluble Trx-VP4 truncated 
protein for the RNA-binding assay in EMSA, I used a similar 
technique to detect the RNA-binding domain of VP4 on 
protein blots (Northwestern assay) . To determine whether 
the VP4 expressed in E. coli retained RNA-binding activity, 
a Northwestern assay was carried out using VP4 expressed 
both in insect cells and in E. coli (Trx-VP4). The VP4 
expressed in insect cells was used as a positive control. 
As shown in Fig. 15, the VP4 proteins expressed in both 
systems have ssRNA-binding activity. The RNA-binding 
efficiency of VP4 in the Northwesterr. assay was not 
equivalent to the amount of protein on the membrane, but 
might result from different renaturing efficiencies of VP4 
on membranes. The ssRNA-binding capability of VP4 on the 
protein blot was also sensitive to 0.15 M NaCl. When an 
RNA-bound protein blot was washed with TBST (10 mM Tris-
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HCl, pH 8, 150 mM NaCl, 0.3 % Tween-20), the bound RNA was 
released from the protein (data not shown). This result 
corresponded to that obtained from the poly(U)-sepharose 
column (Fig. 14). The same technique was also used to map 
the RNA-binding domains on protein blots with Trx-VP4 and 
truncated VP4 proteins. The identities of Trx-VP4 and the 
truncated VP4 proteins were confirmed by anti-VP4 OAbs 
(Fig. 16). 
The truncated mutants ~1B and ~58, which have only 
amino acid residues #1-111 and #1-76, respectively, lack 
ssRNA-binding activity (Fig. 17). In contrast, the 
truncated mutant ~81, which has am1no acid residues #1-
158, and all other mutants were able to bind to labeled 
ssRNA. An interpretation is that a ssRNA-binding domain 1s 
located between amino acid residues #112-158. To determine 
if residues #112-158 represent the only ssRNA-binding 
domain, an N-terminal truncated Trx-VP4 was constructed 
(mutant ~67), which deleted amino acid residues #1-298. 
The identity of mutant ~67 was confirmed by OAb #82. As 
seen in Fig. 16, mutant ~67 was not able to react with OAb 
#81, which recogn1zes the N-terminus of VP4, but did react 
with OAb #82, which recognizes the C-terminus of VP4. As 
seen in Fig. 17, mutant ~67 retained ssRNA-binding 
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activity. This result lS evidence that there lS at least 
one more ssRNA-binding domain of VP4, in the region between 
residues #299-644, in addition to the one located in the 
#112-158 reglon. 
Many studies have shown that RNA-binding domains 
contain clusters of basic amino acid residues (Merrill et 
al., 1988; Lazinski et al., 1989; Nagai et al., 1990; Lee 
et al., 1993; Waksman et al., 1993; Hayama and Li, 1994). 
Many lysine and arginine clusters are found in VP4, which 
could function as RNA-binding sites. In the studies of BTV 
VP6, Hayama and Li (1994) used sequence-specific peptides 
to map the RNA-binding domains of VP6. A similar technique 
was used to map other RNA-binding domains of VP4. 
Peptides of VP4, 9 to 13 residues ln length, were used 
ln EMSA and Northwestern assays to map ssRNA-binding 
domains. As shown in Fig. 18, peptides #76, 77, 80, and 31 
retarded ssRNA in EMSA and bound ssRNA on the membrane in 
the Northwestern assay. Peptide #77 has a lower binding 
affinity. Peptide #78 has no ssRNA-binding activity in 
either the EMSA or Northwestern assay. Therefore, these 
four regions represented by the peptides are the potential 
ssRNA-binding domains of VP4. The binding ability of these 
peptides to dsDNA and dsRNA of the BTV genome was 
investigated. We found that the same peptides that bind to 
ssRNA were able to bind to BTV dsRNA, and none of the 
peptides was able to bind dsDNA (data not shown) . Thus, 
t hese pept i des have specific binding activity to RNA 
instead of to any type of nucleic acids. 
Translational efficiency of 
capped and non-capped 
Ml mRNA 
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It ls assumed, but has not been proven, that BTV mRNAs 
are capped. I decided to investigate whether the cap 
structure of the BTV mRNA is required for translation and 
whether capped and non-capped BTV mRNAs synthesized in 
vitro have different translational efficiencies. Both 
capped and non-capped BTV-13 M1 mRNAs were transcribed as 
described in Materials and Methods. These mRNAs w_ere used 
for in vitro translation with wheat germ extracts 
(Promega). As shown in Fig. 13A, equal amounts of both 
capped and non-capped BTV M1 mRNA (0.06 pg) in 10 ~1 of the 
wheat germ translation mixture had a similar efficiency of 
translation. This result implies that the cap structure of 
BTV mRNA is not required for translation (at least not ln a 
wheat germ system). The in vitro translated VP4 was 
.. 
soluble, and it was found in the supernatant fraction after 
centrifugation at 10,000x g for 10 min (data not shown). 
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Oligomerization of VP4 
Leucine-zipper motifs are known to be responsible for 
protein dimerization (Landschulz et al., 1988) and 
trimerization (Sorger and Nelson, 1989). Therefore, the 
possibility that VP4 forms an oligomer through its leucine-
zipper was investigated. In vitro translated VP4 labeled 
with [35S]-methionine was incubated with glutaraldehyde for 
varlous times. After the chemical cross-linking, the 
product was resolved by SDS-PAGE and examined by 
autoradiography. As shown in Fig. 19, in the presence of 
cross-linker and increased incubation time, the amount of 
VP4 monomer (75 kDa) decreased and the amount of oligomeric 
protein increased. By comparison with known size markers, 
the molecular weight of the VP4 oligomer was estimated to 
be around 600 kDa. This is evidence that VP4 forms a high 
molecular weight oligomer, probably an octamer in solution. 
In the Coomassie blue stained SDS-PAGE that separated the 
chemically cross-linked products, most of the translation 
factors were not cross-linked. This is evidence that the 
cross-linking was specific. Since the oligomerization of 
Hsp104 of Saccharomyces cerevisiae is affected by the 
presence of ATP (Parsell et al., 1994), and VP4 is a GTP-
binding protein (Le Blois et al., 1992), the effect of 
ribonucleotides (rNTP) on VP4 oligomerization was 
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investigated. Oligomerization of VP4 was not affected by 1 
mM of each individual rNTP in the cross-linking mixture 
(data not shown) . 
To investigate whether the leucine-zipper motif is 
required for oligomerization, a cross-linking experiment 
was performed using the leucine-zipper deleted mutant 
(VP4~LZ). In this case, another bifunctional cross-
linker, dimethyl suberimidate dichloride (DMS), was used 
for the cross-linking reactions. DMS is an imidoester 
homobifunctional cross-linker that reacts with primary 
amines on proteins and has a short spacer arm 11 A in 
length. As shown in Fig. 20, when truncated VP4~LZ was 
exposed to increasing concentrations of DMS, the monomer 
was converted into an oligomer. These results are evidence 
that VP4~Z is oligomeric in solution. 
DISCUSSION 
Each BTV virion has an estimated 5 to 10 molecules of 
VP4 inside the inner core (Huismans and Van Dijk, 1990). 
Although VP4 has been suggested to be the guanylyl-
transferase of BTV because of its GTP-binding activity (Le 
Blois et al., 1992), GTP-binding and capping activity have 
not been demonstrated in purified VP4. No other properties 
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of this protein have been discussed. In this report, I 
have expressed and purified recombinant VP4 protein to near 
homogeneity, identified it as a RNA-binding protein, mapped 
several RNA-binding domains and antigenic epitopes, and 
demonstrated that VP4 exists as a high molecular weight 
oligomer. 
Recombinant VP4 expressed in insect cells using the 
baculovirus expression system was mostly insoluble even 
though it has a high content of hydrophilic amino acids 
(Huang et al., 1993). After the cells infected with 
recombinant baculovirus carrying the Ml gene were lysed by 
detergents, freeze and thaw cycles, or sonication, only 
very small amounts of soluble recombinant VP4 were detected 
by immunodetection (data not shown) . The expression of 
recombinant VP4 in insect cells started at 24 hr 
postinfection. The expressed VP4 aggregated rapidly and 
became insoluble immediately after its synthesis (data not 
shown) . Expressing VP4 as a GST-VP4 fusion protein in 
insect cells failed to increase the amount of soluble VP4 
(data not shown) . Co-expressing VP4 and another inner 
minor core protein, VP6, did not increase the production of 
soluble VP4 (Appendix C) . The Ml gene was also cloned into 
the pHIL-Sl (Invitrogen) yeast (Pichia pastoris) expression 
vector. VP4 expressed in this system was fused with a 
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secretion signal from acid phosphatase (PH01). We expected 
the expressed VP4 to be secreted into the growth media of 
yeast. However, the expressed VP4 aggregated in the yeast 
and was never secreted into the growth media (data not 
shown ) . 
VP4 remained ln insoluble aggregates when expressed in 
different strains of E. coli as GST-VP4 and Trx-VP4 fusion 
proteins. These fusions often increase the solubility of 
the expressed protein. By expressing VP4 as 6-histidine 
(6xH) tagged fusion proteins, VP4 was purified in the 
denatured state using a metal affinity column in the 
. 
presence of urea (Appendix B) . When VP4 was expressed at 
15° C, more soluble proteins were produced. However, the 
yield was reduced tremendously. After deleting 400 amino 
acid residues from the C-terminus, VP4 was expressed in a 
soluble form. 
I took advantage of the fact that VP4 aggregates to 
separate it from most of the cellular proteins by 
centrifugation. By using the anionic detergent N-lauroyl 
sarcosine in the presence of DTT and TX-100, I was able to 
solubilize and dissociate the VP4 from the aggregcttes, and 
let it refold to soluble form by dialysis. Because VP4 
fcrms an oligomer, I was able to purify it to near 
homogeneity uslng a slzlng column and a discontinuous 
sucrose gradient (Fig. 7). 
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Six OAbs against VP4 were produced uslng VP4 peptides 
predicted by the PlotStructure program of the GCG package. 
These six OAbs have different reactivities against VP4 in 
Western blots against denatured VP4 (Fig. 8) and in ELISA 
against native and soluble VP4 (Fig. 9). The result (Fig. 
9) that all of the OAbs were able to bind to VP4 in its 
native form ln ELISA is evidence that these epitopes are 
located on the surface of the protein. OAb #76 (1:250) had 
a very weak reaction to denatured VP4 (Fig. 8) but had a 
strong reactivity to the native VP4 in ELISA (Fig. 9). 
This is evidence that the conformation of the peptide #76 
region (residues #617-626) is important for this antibody 
to interact. It ls difficult to conclude that this region 
ls a conformational epitope, since this region is only 9 
amino acid residues in length. The surface accessibility 
of peptides #76, 80, and 81 was confirmed by peptide 
competition against two MAbs against VP4 (Fig. 10). 
Because peptides #76, 80, and 81 were able to block the 
binding activity of MAb D3.6.24 to VP4, and these regions 
are located at different locations (residues #617-626, 
#376-385, and #103-115), I hypothesize that MAb D3.6.24 
recognizes a conformational determinant composed of three 
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regions of the prlmary structure of VP4. This hypothesis 
is supported by the ELISA results (Fig. 9) and lS 
consistent with predictions of the PlotStructure program 
(Fig. 21). All of the peptide regions are probably surface 
located. The results of peptide blocking (Fig. 10) are 
evidence that both termini of VP4 and the middle of VP4 
might come together in its native state. 
This is the first report to show that VP4 is a ssRNA-
binding protein. The ability of VP4 to bind ssRNA was 
demonstrated using EMSA (Fig. 11), binding to poly(U)-
sepharose (Fig. 14), and Northwestern assay (Fig. 16). The 
ssRNA-binding activity of the purified recombinant VP4 
could be competed out by unlabeled BTV ssRNA homologously 
and by yeast tRNA heterologously (Fig. 12). This is 
evidence that the binding of VP4 to ssRNA is not sequence-
specific. 
Four potential RNA-binding domains were mapped uslng 
truncated Trx-VP4 fusion proteins and sequence-specific 
peptides for the RNA-binding assay (Fig. 17 and 18). These 
regions are located at amino acid residues #103-115 
(ENEIGRRRIRMRK), #376-385 (RDRGTFLKKR), #583-592 
(KEQKLRDLKR), and #617-626 (RALREYKRK). These regions are 
surface accessible to VP4 (Fig. 9 and 16) and are rich ln 
basic amino acid residues (Rand K), which are found in 
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many RNA-binding proteins (MeYrill et al., 1988; Lazinski 
et al., 1989; Nagai et al., 1990). 
Two classes of eukaryotic and prokaryotic RNA-binding 
proteins have previously been identified. One contains the 
RNA-recognition motif (RRM), which consists of 80 amino 
acids with two conserved sequences, RNP-1 and RNP-2, of 8 
and 6 amino acids, respectively (Bandziulis et al., 1989; 
Mattaj, 1989). The other one ls classified as the 
arginine-rich motif (ARM) family (reviewed in Mattaj, 
1993) . These RNA-binding proteins bind to RNA through 
short, arginine-rich sequences (4 to 8 arginines in a 
stretch of 10-20 amino acids). They have been found 1n some 
RNA viruses (tat and rev protein of HIV-1), bacteriophages 
(theN protein of bacteriophage lambda), and ribosomal 
proteins (Lazinski et al., 1989). The ARM sequence itself 
is sufficient for RNA recognition. There is little 
sequence identity among ARMs, and most of the ARM proteins 
do not share a common structure. The RNA-binding peptides 
of VP4 are similar to the ARM family. After three RNA-
binding domains were deleted, the truncated VP4 was still 
able to bind to RNA (Fig. 17). This is evidence that the 
RNA-binding activity of VP4 dose not require the 
coexistence of the four RNA-binding domains to be 
functional. A similar result was found in the BTV VP6 
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protein. Since there are multiple RNA-binding domains of 
VP6, only one domain is sufficient for the RNA-binding 
(Hayama and Li, 1994). This is different in hepatitis 
delta virus antigen (HDAg), which has two ARMs, and both 
are required for the RNA-b~nding activity. Deletion of 
either one of these ARM sequences resulted in the total 
loss of the in vitro RNA-binding activity of HDAg (Lee et 
al., 1993). Perhaps, each the different RNA-binding 
domains of VP4 is involved in different functions, such as 
RNA capping, encapsidation, transcription, or replication. 
One RNA-binding domain of VP4 was mapped between amino 
acid residues #112-158 that has four amino acid residues 
(112-RMRK-115) that overlap the RNA-binding peptide #81 
(103-ENEIGRRRIRMRK-115) (Fig. 18). However, the truncated 
mutant #~1B (amino acid residues #1-111) was not able to 
bind the ssRNA (Fig. 17). An interpretation lS that the 
sequence 112-RMRK-115 lS very important for the ssRNA-
binding of VP4. 
Although a leucine-zipper motif lS found in many 
nucleic acid binding proteins, it lS not required for 
ssRNA-binding of VP4 (Fig. 14 and Fig. 17). Similar 
observations were found in the rotavirus VP2 protein (Labbe 
et al., 1994) and the reovirus sigma 3 protein (Miller and 
Samuel, 1992). 
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From the chemical cross-linking experiment (Fig. 19), 
VP4 was identified as an oligomer in solution. In the case 
of HDAg, oligomerization is required for RNA replication 
(Xia and Lai, 1992) but is not required for RNA binding 
(Lin et al., 1990). When VP4 proteins wer~ cross-linked 
with glutaraldehyde, only the VP4 monomer and oligomer 
appeared (Fig. 19). The same results were obtained with 
other types of cross-linking agents [e.g. ethyl glycol-
bis(succinic acid) N-hydroxysuccinimide, dimethyl 
pimelimidate dihydrochloride] (data not shown) . Reducing 
the concentration of glutaraldehyde to 0.005% or the 
. 
reaction temperature to 0° C did not inhibit oligomer 
formation (data not shown) . The VP4 oligomer was not able 
to enter a native gel, but was able to enter the gel 1n the 
presence of 0.1% SDS (data not shown). The addition of 400 
mM NaCl, 16 mM B-mercaptoethanol, or 40% glycerol to the 
protein mixture did not allow VP4 to enter the native gel. 
This is evidence that the exclusion of VP4 ls not the 
result of nonspecific interactions with other proteins. 
Although the chemical cross-linking experiments established 
that VP4 may be an octamer, more data have to be obtained 
to confirm these results, such as gel filtration 
chromatography and electron-microscopy using the purified 
VP4. 
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The leucine-zipper motif ls not required for VP4 
oligomerization (Fig. 20). A similar observation was also 
found in measles virus (Buckland et al., 1992) and 
Newcastle disease virus (NDV) (Reitter et al., 1995). The 
leucine-zipper motifs of the measles virus and NDV fusion 
proteins are not required for their oligomerization but are 
essential for fusion. Whether the leucine-zipper motif has 
any function in VP4 is unknown. In the deduced amino acid 
sequences of BTV VP1 proteins, two leucine-zipper motifs 
were identified (Huang et al., 1995). Perhaps VP4 
interacts with VP1 through the leucine-zipper motifs, and 
forms a complex to regulate the transcription and 
replication of BTV. 
In the Northwestern assay, the VP4 monomer was able to 
bind ssRNA (Fig. 16). However, we cannot rule out that 
during the refolding procedures VP4 formed its oligomer 
structure. Whether the oligomerization of VP4 ls required 
for its RNA-binding is not clear. The VP4 native structure 
is required for the RNA binding, since SDS-denatured VP4 
lost RNA-binding activity (Fig. 12). 
In the study of the rev protein of human immuno-
deficiency virus type 1 (HIV-1), tetramerization is 
required for RNA binding (Zapp et al., 1991), and both the 
oligomerization and RNA-binding domains are located at the 
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arginine-rich reglons. Whether VP4 uses the same mechanism 
for RNA binding and oligomerization ls unknown. 
Presently, five BTV proteins have been shown to 
possess ssRNA-binding activity. These include VP1 (Urakawa 
and Roy, 1989), VP3 (Loudon and Roy, 1992), VP4 (this 
study), VP6 (Hayama and Li, 1994), and NS2 (Huismans et 
al., 1987; Thomas et al., 1990; Zhao et al., 1994). 
Interestingly, none of these BTV proteins bind ssRNA ln a 
sequence-specific manner. This contrasts with the 
situation in rotavirus, in which some of the RNA-binding 
proteins (VP1, NSP1, and NSP3) possess specific affinity 
for rotavirus mRNA, and others (VP2, NSP2, and NSP5) have 
nonspecific binding activity (Patton, 1995). How BTV 
specifically encapsidates the 10 mRNAs through these 
nonspecific RNA-binding proteins still needs to be 
answered. 
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FIG. 6. Expression of VP4 in a baculovirus expresslon 
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system. (A) Coomassie blue stained SDS-PAGE; Lane 1 and 2: 
insect cells infected with recombinant baculovirus carrylng 
BTV-13 M1 gene at an M.O.I. of 10 and 5, respectively; Lane 
3: mock infected insect cells; Lane M: molecular weight 
markers. (B) Immunodetection of the same sample as 
described ln (A) with PAb against BTV-13 virion at 1:1,000 
dilution. (C) same as (B) except the antibody was pre-
immunized rabbit serum as a negative control . 
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FIG. 7. SDS-PAGE analyses of purified BTV-13 VP4 from the 
baculovirus expression system. VP4 purified by Sephadex G-
75 column was resolved by an SDS-PAGE and stained by (A) 
Coomassie blue and (B) silver. Lane 1 to 5 are two-fold 
dilutions of VP4. 
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FIG. 8. Western blot immunodetection of VP4 by OAbs. VP4 
was transferred to a nitrocellulose membrane after gel 
el e ctrophoresi s through a 7.5 % SDS-polyacrylamide gel. The 
dilution s of OAb #76 and #77 were 1:250 and 1:500; the 
di lut ions of OAbs are showed above the lanes ; pre-immuned 
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FIG. 9. Binding of anti-VP4 MAbs and OAbs to purified VP4 
ln ELISA. The degree of binding of these antibodies to VP4 
was measured by the binding of alkaline phosphatase-
conjugated second antibodies and the optical density at 405 
nm. Pre-immuned rabbit serum and anti-VP6 MAb (Hayama and 
Li, 1994) were used as negative controls. The dilutions of 
each antibody were 1:10, 1:100, 1:1,000, and 1:10,000. 
Each point represents the average of three replicates. 
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FIG. 10. Competition binding of two anti-VP4 MAbs to VP4 
by synthetic peptides. MAb D3.6.24 and D3.10.1 were cross-
absorbed with VP4 sequence-specific peptides #76, #77, #78, 
#80, and #81 before they were used for immunodetection. 
(A) MAb D3.6.24; (B) MAb 03.10.1. Lane M: pre-stained 
molecular weight markers (Bio-Rad); Lane B: negative 
control; Lane C: MAb without cross-absorption. The band 
across the blots above VP4 is due to the second antibody 
cross-reaction. 
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FIG. 11. EMSA of ssRNA-binding activity of VP4. (A) 
Various amount s of purified BTV-13 VP4 were used to react 
with [ 32 P]-labeled c apped RNA transcripts of BTV M1 gene. 
Lane 1: labeled transcript without VP4 as control; Lane 2: 
20 ng of VP4; La e 3 : 40 ng of VP4; Lane 4: 80 ng of VP4. 
(B) Competiti on betwe en capped and non-capped RNA for VP4 
binding. Var ious amounts of unlabeled non-capped BTV-13 M1 
transcripts were added to the reacti on mixture and the 
experiment was per a r med a s in (A) . Lane 1: no competitor 
. RNA; Lane 2 : 1 0 0 ng ; Lane 3 : 2 0 0 ng; Lane 4 : 4 0 0 ng of 
unlabeled non- e pped ssRNA. 
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FIG. 12 Compet ition between tRNA and BTV ssRNA for VP4 
binding in EMSA. Lane 1: Labe led [ J ~ P]-RNA without VP4 as 
control; Lane 2: 40 ng of VP4; Lane 3 : 80 ng of VP4; Lane 
4: 500 ~g of yeast tRNA was included in the reaction 
mixture; Lane 5: same as lane 3 except 1 % SDS was adde d ln 
the reaction mixture; Lane 6: ssRNA was incubated with 
RNase A. 
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FIG. 13. In vit ro t ranslation of BTV-13 VP4 and an internal 
deletion mutan t (/P4 ~LZ) with wheat germ extract. (A) 
Translation of intac t VP4 from the capped RNA transcript of 
the M1 gene (L ane 1) and from non-capped M1 gene transcript 
(Lane 2). (B) Transl ations of the intact M1 gene 
transcript (Lan e 1) and internal M1 deletion mutant which 





12 3 4 56 7C 
-- VP4~LZ 
B 
FIG. 14. Profiles of VP4 and VP4~LZ eluted from a 
poly(U)-sepharose column . In vitro translated proteins 
labeled with [35S]-methionine were applied to a poly(U)-
sepharose column, eluted with 0.15 M NaCl, and collected. 
The eluants were precipitated with TCA and resolved in SDS-
PAGE and autoradiographed. The numbers indicate fraction 
numbers. (A) In tact VP4 ; (B) Truncated VP4 with leucine-
zipper regi on deleted (VP4~LZ). 
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FIG. 15. Northwestern assay of VP4 expressed in insect 
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cells and E. coli. VP4 and Trx-VP4 are indicated by arrow 
heads. (A) Expressed VP4 probed with [ 32 P] -ssRNA. (B) 
Immunodetection to the same membrane with OAb #82. Lane 1-
3 were VP4 expressed in SF-9 cells with about 0.5, 1, and 2 
pg of proteins, respectively. Lane 4-6 were Trx-VP4 fusion 
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Immunodetection of Trx-VP4 and the truncated VP4 
OAbs # 78, 80, 81, and 82 were used for the 
detection at a dilution of 1:1000. 
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FIG . 17. Hap ing the ssRNA-binding domains of VP4 with 
No rthwes cr1 c-- ~, u .. l-4.~~. ) ' [ - p] -ssRNA was used to probe 
i mmobilized TP4 and he truncated VP4 proteins on a 
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riG. 18 . s sRNA- binding activity of VP 4 sequence -specific 
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p pt:l es . (A) No rthwestern assay. Bi o tinylated ssRNA was 
used o p robe the immobilized peptides on nitrocell ulos e 
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FIG . 19. Chemical cross-linking of ~n vitro t r a nsl a ted 
VP4 . Translated VP4 was incubated with 0.01 ~ 
glutaraldehyde for 1, 2, and 4 min at r oom t emp e rature. 
Cro s s -linked products were analyzed by 3 . 5 ~ SDS-PAGE . 
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FIG. 20. Chemical cross-linking of VP4 with deleted 
leucine-zipper motif (VP4~LZ). In vitro translated 
truncated VP4 protein lacks the leucine-zipper motif 
(VP4~LZ) was incubated with 2.5, 5 , and 10 rnM of DMS at 
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room temperature for 25 min and analyzed on 7.5 % SDS-PAGE. 
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CHAPTER IV 
CONCLUSION AND DISCUSSION 
Bluetongue Vlrus (BTV) ls the agent that causes 
bluetongue disease in ruminants. The mechanism of BTV 
replication is still largely unknown. The transcription of 
BTV ssRNA and the replication of BTV dsRNA were assumed to 
be controlled by three lnner core proteins: VP1, VP4, and 
VP6. The functions of these inner core proteins are still 
not clear. VP1 is the potential RNA-dependent RNA 
polymerase (Urakawa and Roy, 1989) . VP6 is a DNA- and RNA-
binding protein (Hayama and Li, 1994). VP4 is another 
minor inner protein of BTV, and its function is unknown. 
To understand the replication of BTV, the function of each 
viral protein must be known. In this study, the gene (M1) 
coding for VP4 was cloned and sequenced. VP4 was expressed 
and purified in order to study its functions. 
Phylogenetic study of BTV 
using Ml genes 
The length of five M1 genes determined in this study is 
1981 nucleotides, 30 nucleotides shorter than that of the BTV 
serotype-10 reported by Yu et al. (1987). The 5'- and 3'-
noncoding regions of all five M1 genes are identical among 
all serotypes. The M1 gene possesses a single, long ORF that 
135 
encodes 644 amino acid residues. A potential leucine-zipper 
motif was identified near the carboxyl terminus of the 
deduced VP4 amino acid sequence. There is a high degree of 
sequence conservation among the five US BTV VP4 proteins 
with f e wer than 4% mismatches in their amino acid sequences 
(Table 2). The phylogenetic analysis using the sequences of 
these five cognate M1 genes yielded results consistent with 
our previous phylogenetic studies of cognate genome segments 
1, 3, 5, 6, 8, 9, and 10. Serotypes-10, -11, -13, and -17 
are closely related, and serotype-2 is the most distantly 
related among the five US BTVs (Fig. 4). 
Characterization of VP4 
Recombinant VP4 was expressed and found to be highly 
insoluble in both eukaryotic (insect cells and yeast) and 
prokaryotic (GST-, Trx-, and 6xH-fusion proteins) systems. 
When detergents and reducing agents were combined, the 
heterologously expressed VP4 was able to be solubilized and 
purified to near homogeneity (Fig. 7). The recombinant VP4 
possessed a ssRNA-binding activity in both the EMSA (Fig. 
11) and the Northwestern assay (Fig. 15). VP4 protein has 
binding activity to both capped and non-capped ssRNAs. Its 
RNA-binding activity was not specific to BTV ssRNA as it 
was demonstrated that in vitro translated VP4 could bind to 
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poly(U)-sepharose (Fig. 14), and its BTV ssRNA-binding 
activity could be competed out by yeast tRNA (Fig. 12). 
Although a leucine-zipper motif is found in many proteins 
(summarized in Table 5) including nucleic acid binding 
proteins, the leucine-zipper of VP4 is not required for the 
RNA binding (Fig. 14 and 17). 
An RNA-binding domain was mapped between amlno acid 
residues #112-158. AnN-terminal truncated VP4 was 
constructed (mutant ~67) to invest~gate whether residues 
#112-158 are the only ssRNA-binding domain. The mutant 
~67, which lacks amlno acid residues #112 to 158, retained 
ssRNA-binding activity (Fig. 17). This suggests that more 
than one ssRNA-binding domain exists in VP4. 
To identity other potential ssRNA-binding domains of 
VP4, sequence-specific synthetic peptides corresponding to 
VP4 in the arginine- and lysine-rich regions were used ln 
EMSA and Northwestern assays (Fig. 18). These regions are 
located at amino acid residues #103-115 (ENEIGRRRIRMRK), 
#376-385 (RDRGTFLKKR), #583-592 (KEQKLRDLKR), and #617-626 
(RALREYKRK) . These sequences are rich in basic amino acid 
residues (Rand K), which are found in many of the RNA-
binding proteins (Merrill et al., 1988; Lazinski et al., 
1989; Nagai et al., 1990). These regions are also surface 
accessible on VP4 (Fig. 9 and 21) and thus are more 
137 
available for binding to RNA. The RNA-binding domains are 
summarized in Fig. 23. 
VP4 was suggested as an oligomer based on chemical 
cross-linking experiments (Fig. 19), but additional data 
have to be collected to confirm this conclusion. The 
leucine-zipper motif lS not required for the 
oligomerization (Fig. 20), although it is responsible for 
oligomerization in some other proteins (Landschulz et al., 
1988; Sorger and Nelson, 1989). Whether the 
oligomerization of VP4 is required for its RNA-binding 
activity is not clear. The nondenatured form of VP4 is 
required for the RNA-binding; in the presence of SDS, VP4 
was not able to bind ssRNA in EMSA (Fig. 12). 
Mapping the antigenic 
epitopes of VP4 
Six antigenic epitopes were mapped at am1no acid 
residues #617-626 (RALREYKRKM), #583-592 (KEQKLRDLKR), 
#167-178 (GARFDDEPTDEK), #376-385 (RDRGTFLKKR), #103-115 
(ENEIGRRRIRMRK), and #523-551 (RVESSVLRVRNPTLHETADELK 
RMGLDL) (Fig. 8). These regions are also surface 
accessible as shown in ELISA (Fig. 9). Peptide competition 
assays for blocking two monoclonal antibodies (D3.6.24 and 
D3.10.1) also confirmed that #617-626, #376-385, and #103-
115 are surface accessible (Fi g. 9) and that the two 
antigenic determents are conformational. 
Potential function of VP4 
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Although VP4 is the candidate for being the BTV 
guanylyltransferase, its sequence is not similar to any of 
the known guanylyltransferases and capplng enzymes. Using 
the FASTA program of GCG to search for homology between VP4 
and other known proteins, I found that amino acid residues 
between #7 and #41 have 47.6% identity in a 21-amino acid 
overlap to the RNA-directed RNA polymerase of human 
respiratory syncytial virus, which is a ssRNA Vlrus. This 
region also has 33.3% identity in a 21-amino acid overlap to 
the RNA-directed RNA polymerase of kunjin virus, which ls 
also a ssRNA virus (Fig. 22A). Another region between amlno 
acid residues #533-587 was also found to have 27% identity ln 
a 37-amino acid overlap to the B-subunit of the RNA 
polymerase of vesicular stomatitis virus, which ls a ssRNA 
Vlrus. The same region also has 37.5% of identity ln a 16-
amino acid overlap to the RNA-directed RNA polymerase (ORF1A) 
of coronavirus (Fig. 22B). One of the common characteristics 
of these RNA polymerases is that they are multifunctional 
proteins. They may be involved in RNA synthesis, capplng, 
and methylation. Perhaps VP4 interacts with VP1, the BTV RNA 
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polymeras e, to form the transcription and replication complex 
through leucine-zipper motifs predicted from both proteins. 
Future research of VP4 
This is the first report in which the BTV VP4 protein 
has been purified to near homogenity and identified as a 
ssRNA-binding protein, although the structure and 
functional domains were mapped using recombinant VP4 
proteins and sequence-specific peptides. To confirm the 
RNA-binding domains of VP4, crystallization is required. 
The technique developed for purifying VP4 can be used to 
prepare large amounts of VP4 for crystallization. The same 
technique may also be applied to purify other BTV proteins 
that are expressed as insoluble forms. 
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TABLE 5 
Summary of the Functions of Leucine-Zipper 
Motif in Some of the Known Proteins 
Protein Function Reference 
Yeast, heat shock 
transcription factor 
Trimerization Sorger and Nelson, 
1989 
Yeast, GCN4 









Measles Vlrus, fusion Fusion 
protein 
Pu and Struhl, 1991 
Leone et al., 1991 
Xia and Lai, 1992 
Buckland et al. , 
1992 
Newcastle disease Fusion Reitter et al., 
virus, fusion protein 1995 
Fujinami sarcoma Trans-activation of Park and Seo, 1995 
virus, p130-gag-fps tyrosine kinase 
Marek's disease Dimerization Qian et al., 1995 
virus, Meq protein 
Human T-cell leukemia Protein-Protein Yin et al., 1995 
Vlrus type-1, CREB1 interaction 
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FIG. 21. Protein structure prediction and epitope 
locations of VP4. The secondary structure of VP4 was 
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predicted using the PlotStructure program of GCG software. 
The locations of six epitopes were marked as black blocks. 
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BTV-13 VP4 7-VLYVTNELSH.IVKNG.FLPIWKLTGDESLNDLWLEN 
Rrpl_Hrsva 389-SDNIINGR . . WIILLSKFLKLIKLAGDNNLNNLS.EL 
Polg_Kunjm 970-NLAIHSDLSYWIESR .. FNDTWKLERAVLGEVKSCTW -- - -
A 
BTV13 VP4 
Rrpl_Vsvsj 874-KYAMLYLDPS.IGGVSGMSLSRFLIRAFPDPVTESLS.FWRF.IHVHAR.SEHLKEMSA - - --- ---- -
B 
FIG. 22. Sequence alignment of VP4 to other proteins using 
FASTA program of GCG software. (A) The amlno acid residues 
between #7 to 41. Rrpl_Hrsva: RNA polymerase of human 
respiratory syncytial virus; Polg_Kunjm: RNA polymerase of 
kunjin virus. (B) The amino acid sequence between #533 to 
587. Rrpl_Vsvsj: RNA polymerase of vesicular stomatitis 
virus; Rrpa_Cmvjh: RNA polymerase of coronavlrus. The 
identical amlno acids are balded and underlined, and 
numbers at left show residue numbers. 
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81 78 80 82 77 76 
RNA-binding 
VP4 87 kDa yes 
~3X 75 468 yes 
~54 41 yes 
~24 40 yes 
~81 32 -168 
yes 
~18 24 --111 no 
~58 20 --76 no 
~67 32 yes 
Synthetic peptides Locations RNA-binding 
#76 RALREYKRKM #617-626 yes 
#77 KEQKLRDLKR #583-592 yes 
#78 GARFDDEPTDEK #167-178 no 
#80 RDRGTFLKKR #376-385 yes 
#81 ENEIGRRRIRMRK #103-115 yes 
FIG. 23. Summary of the truncated VP4 proteins and the VP4 
RNA-binding domains. The locations of the peptides are 
· indicated as arrow heads and are also summarized at the 





RELATED RESEARCH PUBLICATIONS 
APPENDIX A.1 
SEQUENCE ANALYSES AND ANTIGENIC EPITOPE MAPPING OF 
THE PUTATIVE RNA-DIRECTED RNA POLYMERASE OF 
FIVE U.S. BLUETONGUE VIRUSES 1 
I-Jen Huang, 2 Guang-Yuh Hwang, 3 Yi-Yuan Yang, 4 
Emiko Hayama, 2 and Joseph K.-K. Li 2 
147 
1Permission to reprint is granted by Academic Press, Inc. 
2Program in Molecular Biology and Department of Biology, 
UMC 5500 Utah State University, Logan, Utah 84322-5500; 
3Department of Biology, Tunghai University, Taichung, 
Taiwan, Republic of China; and 4Department 
of Medical Technology, Taipei Medical 
College, Taipei, Republic of China 
(Published ln 1995: Virology 214, 280-288) 
ABSTRACT 
We determined the complete nucleotide sequences of the 
cognate Ll double-stranded RNA segment of bluetongue virus 
(BTV) serotypes 2, 11, 13, and 17, which encode the 
putative RNA-directed RNA polymerase VP1. Each Ll gene 
contained 3944 nucleotides and was 10 bases shorter than 
the previously reported L1 gene of BTV 10. A single open 
frame which could encode the reported VP1 protein, 1302 
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amlno acids ln slze, began with an initiation codon at 
nucleotides 12-14 and a termination codon at nucleotides 
3918-3920. Analyses of the nucleotides of L1 gene and the 
deduced amino acid sequences of VP1 proteins of the five 
U.S. BTV serotypes indicated that the most recently 
isolated BTV-2 serotype from Florida was more distantly 
related than BTV-10, -11, -13, and -17, which were isolated 
prlmary in the western U.S.A. The results are consistent 
with our hypothesis that BTVs-10, -11, -13, and -17 are 
derived form a single and common gene pool, and that BTV-2 
belongs to a second, distinct gene pool. These genetic 
distinctions also reflected well with the known geographic 
distribution of the five U.S. BTV serotypes in North 
America. This putative RNA-directed RNA polymerase (149 
kDa) was a basic protein, and the deduced amino acid 
sequences of the VP1 proteins contained seven highly 
conserved hydrophobic domains and many other sequence 
motifs which were also found in other known RNA 
polymerases. Four immunodominant but linear antigenic 
epitopes conserved among the VP1 of five U.S. BTVs were 
also been identified and mapped using monospecific 
oligoclonal antibodies. 
APPENDIX A.2 
CONSERVATION OF THE SEGMENT 4 GENE SEQUENCE AND OF 
A LEUCINE ZIPPER MOTIF IN VP4 AMONG 
FIVE US BLUETONGUE VIRUSES 1 
I-Jen Huang, Emiko Hayama, Yoo-Jin Jeong, 
and Joseph K.-K. Li 
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Utah State University, Logan, Utah 84322-5500, USA 
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P.S. The results of this paper represent part of this 
dissertation. 
ABSTRACT 
Full-length eDNA coples of the segment 4 (Ml) genes of 
US Bluetongue viruses serotype-2, -10, -11, -13, and -17 were 
selectively amplified using genomic double-stranded RNA 
segments from purified BTV virions as templates and a 
modified polymerase chain reaction (Clamp-R) . They were then 
cloned into pUC19 plasmids and both strands of several clones 
were sequenced. The length of all five segment 4 genes lS 
1981 nucleotides, which is 30 nucleotides shorter than that 
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of the BTV serotype-10 reported by Yu et al. The 5'- and 3'-
noncoding regions of all five segment 4 genes are identical 
among all serotypes. The plus sense strand of the BTV 
segment 4 gene, which encodes the VP4 protein, possesses a 
single long open reading frame with an init~ation codon (ATG) 
at nucleotides #9-11 and a stop codon (TAA) at nucleotides 
#1941-1943. This open reading frame encodes for a protein of 
644 amino acid residues with a predicted molecular weight of 
about 75 kDa and a pi of +7 to +7.9. A potential leucine 
zipper motif was detected near the carboxyl terminus of the 
deduced VP4 amino acid sequence. The phylogenetic analysis 
using the sequences of these five cognate segment 4 genes lS 
consistent with the results of our prevlous phylogenetic 
studies of cognate genome segments 5, 6, 8, 9, and 10. 
Serotype-10, -11, -13, and -17 are closely related and 
serotype-2 is the most distantly related among the five US 
BTV serotypes. 
APPENDIX A.3 
EVOLUTIONARY ANALYSES OF FIVE US BLUETONGUE VIRUSES 
USING THE COGNATE S2 GENES 1 
Yang, Y.-Y., Chiou, J.-F., Hwang, G.-Y., 
Huang, I-J., and Li, J.K.-K. 
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Biology, UMC 5500, Utah State University, Logan, Utah 
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Taipei, Taiwan, Republic of China 
(Published 1n 1992: Virus Research 25, 241-249) 
ABSTRACT 
Full-length eDNA coples of S2 genes (segment 8), 
coding for nonstructural protein 2 (NS2) of bluetongue 
virus serotypes 2, 11, 13, and 17 were selectively 
synthesized by a modified polymerase chain reaction (Clamp-
R) and cloned into the Pst I site of the pUC19 plasmid. 
Each of these S2 cognate genes was 1125 nucleotides in 
length with an initiation and a termination codon at 
nucleotides #20-22 and #1082-1084, respectively, resulting 
in a long open reading frame capable of coding a protein of 
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354 amino acids. The deduced amlno acid sequence of NS2 
protein had a high concentration of lysine and contained a 
relatively low number of tryptophan and histidine residues. 
There was a highly conserved hydrophilic region at the 
carboxyl termini of predicted NS2 proteins in all five BTV 
serotypes, even though the amino acid sequence in this 
region in BTV-2 was more variable than in the other four 
serotypes. There was significant sequence homology of the 
cognate S2 genes at both the nucleotide and the amino acid 
levels. Phylogenetic analyses using the S2 gene sequences 
indicated that BTV-10, -11, -13, and -17 were more closely 
related and BTV-2 was the most distantly related serotype 
among the five US bluetongue viruses. 
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EXPRESSION AND PURIFICATION OF BTV-13 
VP4 IN E.COLI 
MATERIALS, METHODS, AND RESULTS 
Expression of VP4 as GST 
fusion protein 
154 
Full-length eDNA of the BTV-13 M1 gene was amplified 
as described in CHAPTER II with a pair of primers anchored 
with a Sma I site (5'-GACGTCGACCCGGGGATGCCTGAGCCA-3' and 
5'-GACGTCGACCCGGGTAAGTTGTACAT-3'). The amplified eDNA was 
cloned into the pGEX2T expression vector (Pharmacia) at the 
Sma I site using the procedures described ln CHAPTER II. 
The orientation of the insert was checked by BamH I enzyme 
digestion. The plasmid containing BTV-13 Ml eDNA 
(pGEX2TBTV13Ml) was then transformed into E. coli TOPP2 
strain (Stratagene) as described in CHAPTER II for 
expresslon. The expressed VP4 was a GST-VP4 fusion 
protein. 
One ml of overnight culture grown in LB containing 50 
pg/ml of ampicillin at 34° C was diluted 8-fold with LB and 
· allowed to grow for 1.5 hr. Isopropyl-B-D-thiogalacto-
pyranoside (IPTG) was added to the culture at a final 
concentration of 0.05 mM as an inducer to initiate the 
protein expression. After 2.5 hr of induction at 34° C, 
155 
the cells were harvested by centrifugation at 4,000 rpm for 
10 min and resuspended in 1 ml of ice-cold MTPBS (150 mM 
NaCl, 16 mM Na2P04, 4 mM NaH2P04, pH 7.3) plus 50 mM EDTA, 1 
mM phenylmethylsulfonylfluoride (PMSF), and 1% TX-100. The 
cells were then lysed by sonication (VirSonic, 80% power 
output) three times (30 sec each) at 4° C and centrifuged 
at 4,000 rpm for 15 mln to separate the soluble and 
insoluble fractions. The expressed GST-VP4 was found 
mainly in the insoluble fraction (data not shown) . By 
lowering the temperature to 15° C for growlng and 
expresslon, the production of soluble GST-VP4 protein 
. 
increased. However, the overall amount of protein 
production was reduced tremendously (data not shown) 
The insoluble pellets were resuspended in 1 ml of 25 
mM triethanolamine, pH 8, 1mM EDTA, and 1.5% N-lauroyl 
sarcosine and incubated at 4° C for 25 min. TX-100 was 
then added to the protein solution to a final concentration 
of 1 %. The solution containing GST-VP4 was then incubated 
with 20 pl of glutathione-conjugated agarose beads (G-
beads, Sigma), pre-equilibrated with the same buffer at 
4° C, for 1 hr to extract the GST-VP4 fusion protein. The 
GST-VP4 bound to the G-beads through the GST moiety. The 
G-beads were then washed 3 times with 1 ml of 100 mM Tris-
HCl, pH 7.5 and 150 mM NaCl, and another 3 times with the 
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cleavage buffer (100 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 
2.5 mM CaCl 2). As shown in Fig. 23A, the G-beads were able 
to extract GST-VP4 from the protein solution with minor 
contamination. The intact VP4 was released from the G-
beads by protease digestion at room temperature with human 
thrombin (0.5 u/ml), which cleaved the junction sequence 
(LVRRGS) between GST and VP4. As shown in Fig. 23B, after 
thrombin digestion, the amount of GST-VP4 fusion protein 
(102 kDa) decreased and the amounts of VP4 (75 kDa) and GST 
(27 kDa) increased. 
Expression of VP4 as 6xH-VP4 
fusion protein 
BTV-13 M1 eDNA was also cloned into the pQE30 (Qiagen) 
expression vector at the Sma I site using the procedures 
described previously. The plasmid carrying the correct 
orientation of BTV-13 M1 eDNA (pQE30BTV13M1) was 
transformed into to E. coli strain M15 (pREP4) (Qiagen) for 
expresslon. VP4 would be expressed as a fusion protein 
tagged with 6-histidines (6xH-VP4) in this system. Ten ml 
of the overnight culture grown at 37° C was diluted with 
growth media at a 1:20 dilution and allowed to grow for 3 
hr. IPTG was then added to the culture at a final 
concentration of 2 mM to initiate the protein expression. 
As shown in Fig. 24, E. coli grown in different media had 
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different efficiencies of 6xH-VP4 protein expression. In 
the comparison of 2xYT (16 g ·bacto-tryptone, 10 g bacto-
yeast extract, and 5 g NaCl per liter), Super Broth (25 g 
bacto-tryptone, 15 g bacto yeast extract, and 5 g NaCl per 
liter), and LB (10 g bacto-tryptone, 5 g bacto-yeast 
extract, and 10 g NaCl per liter), 2xYT gave the best yield 
in the expression of 6xH-VP4, and LB gave the lowest 
efficiency of expression. The 6xH-VP4 was also expressed 
as insoluble inclusion bodies. Lowering the growth and 
induction temperatures, and using different dilutions of E. 
coli culture and induction times did not change the 
formation of inclusion bodies. The expressed 6xH-VP4 was 
then purified in the denatured form using Talon™ resin 
(Clontech), which is a non-nickel immobilized metal 
affinity resin, to purify recombinant 6xH proteins. The 
induced E. coli culture was harvested by centrifugation at 
4,000 rpm for 10 min, and the pelleted cells were 
resuspended in 10 ml of STE (10 mM Tris-HCl, pH 8, 150 mM 
NaCl, 1 mM EDTA) buffer. The cells were lysed by 
sonication 5 times (30 sec each), and the lysed cells were 
then centrifuged at 4,000 rpm for 15 min to separate the 
soluble and insoluble fractions. The insoluble fraction 
containing 6xH-VP4 was dissolved in 10 ml of buffer 
containing 20 mM Tris-HCl, pH 8, 100 mM NaCl, and 6 M 
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guanidine-HCl for 10 mln at room temperature. The protein 
solution was then centrifuged at 10,000x g for 10 min to 
remove any insoluble materials. The majority of 6xH-VP4 
was found in the supernatant (data not shown) . The 
supernatant containing the 6xH-VP4 was then mixed with 1 ml 
of Talon™ resin pre-equilibrated with the same buffer at 
room temperature for 20 min to extract the 6xH-VP4 protein. 
The resin was then washed with the same buffer for 10 min 
to remove unbound proteins. The washed resin was then 
packed into a 10-ml column. Elution buffer (20 mM Tris-
HCl, pH 8, 100 mM NaCl, 8 M urea) containing different 
concentration of imidazole (5 ml of each concentration) was 
used to elute the 6xH-VP4, and 1-ml fractions were 
collected. As shown in Fig. 25, the 6xH-VP4 eluted at 40 
mM imidazole. 
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1 2 M 1 2 3 4 5 
200 .._ GST-VP4 --
116 
GST-VP4 ~ -· - 97 --vP4 
66 
55 
36 ..._ - - --GST 
31 
FIG. 24. SDS-PAGE analyses of purified GST-VP4 fusion 
proteins. (A) GST-VP4 fusion protein purified with 
glutathione-conj ugated aga ro se beads in two preparations. 
Lane M: Molecular weight markers shown as kDa. (B) 
Thrombin cleavage of the purified GST -VP4 fusion protein. 
Lane 1: GST-VP4 fusion protein without thrombin; Lane 2: 10 
mln; Lane 3 : 30 min ; Lane 4: 60 min; Lane 5: 90 min 
incubation with thrombin at room temperature. The gels 
were stained with Coomassie blue . 
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Super Broth L Broth 2XYT 
br/pi 1 2 3 4 5 1 2 3 4 5 c 1 2 3 4 5 
··' 
') 100 
116 -. - '": 97 
VP4~ -- 66 
55 
FIG. 25. SDS-PAGE analyses of the 6xH-VP4 fusion proteins 
expressed in different growth media. E. coli carrying 
pQE30BTV13Ml plasmid was grown in Super Broth, LB, and 2xYT 
media, respectively and induced with 2 mM IPTG for protein 
expresslon. The samples were analyzed on a 7.5 % SDS-PAGE 
and stained with Coomassie blue. Numbers on top of the gel 
represent the hours post induction (hr/pi). Molecular 
weights were indica ed on the right side of the figure 
( kDa) . 
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R M 2 3 4 5 6 7 
6xH-VP4 -..... 1--
-1 ' 
8 9 10 11 12 13 14 15 16 17 18 19 20 
21 22 23 24 25 26 27 28 29 30 31 32 33 
6xH-VP4 ~ . --
FIG. 26. Purif ica tion of 6xH- VP4 under denaturing 
conditions . Expre ssed 6xH-VP4 was extracted by Talon™ 
resin and elut ed wi th 5 ml of 10 mM (Lanes 1 to 5), 20 mM 
(Lanes 6- 10) , 4 0 mM (Lanes 11 to 15) , 80 mM (Lanes 16 to 
20), 100 mM (Lanes 21-25) , and 200 mM (Lane s 26 to 33) 
imidazole in t he e lution buffer . One-ml fr actions were 
collected and 1 0 p l of each frac lon were analyzed on 7.5 % 
SDS-PAGE an st ained with Coomassie blue . Lane M: 
Molecular weigh t ma rkers (200 , 11 , 97 , 66 , and 55 kDa). 
Lane R: Talonr 1 re sin with bound xH-VP4 . 
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COEXPRESSION OF VP4 AND VP6 IN INSECT CELLS 
MATERIALS, METHODS, AND RESULTS 
Because VP4 that was expressed in both eukaryotic and 
proka r yotic cells was ln the insoluble form, I investigated 
whether co-expressing it with another inner core protein 
would increase its solubility in insect cells. BTV-13 Ml 
and S3 (codes for VP6) cDNAs were cloned into the pAcUW51 
(Invitrogen) baculovirus expression vector. The vector has 
two promoters (p10 and polyhedrin) to express two genes ln 
the same insect cell. Full-length BTV-13 S3 eDNA was 
amplified as described in CHAPTER II using a pair of prlmer 
anchored with an EcoR I site (5'-GGATCCGAATTCGTTAAAA 
AATCGCATAT-3' and 5'-GGATCCGAATTCGTAAGTGTGAAATCGCC-3') and 
cloned into the vector pAcUW51 at the EcoR I site 
(pAcUW51BTV13S3). Two pg of the pAcUW51BTV13S3 plasmids 
were then digested with the BamH I restriction enzyme ln 20 
pl of reaction mixture. To fill ln the BamH I digested 
sticky ends to generate blunt ends, 1 pl of each 0.5 mM 
dNTP and 5 units of Klenow were added to the mixture and 
incubated 15 min at 30° C. The blunt-ended plasmids were 
then purified by phenol/chloroform and ethanol precipitated 
as described in CHAPTER II. The BTV-13 M1 eDNA digested 
with Sma I (also blunt ended) was ligated to the blunt-
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ended linear pAcuW51BTV13S3 plasmid to construct the 
pAcuW51BTV13S3-M1 plasmid. The plasmid construction was 
summarized in Fig. 26. The plasmid purification and co-
transfection with linear viral DNA were according to the 
procedures described in CHAPTER III. As shown in lane T of 
Fig. 27, the recombinant baculovirus infected insect cells 
expressed both VP4 and VP6. However, the expressed VP4 was 
mainly in the insoluble portion (Lane P, Fig. 27), whereas 
VP6 was soluble (LaneS, Fig. 27) . · To investigate whether 
VP4 and VP6 formed a complex in vivo, co-immunoprecipita-
tion was carried out with anti-VP6 MAbs (D34.5.7, D12.4.20, 
and H13.1). Insect cells infected with recombinant 
baculovirus were harvested after 72 hr post infection and 
lysed in lysis buffer (50 roM Tris-HCl, pH 7.5, 150 mM NaCl, 
1 mM EDTA, 0.1% NP-40). The lysed cells were centrifuged 
to separate the soluble and insoluble fractions. Fifty pl 
of each MAb were mixed with 250 pl of the supernatant, and 
incubated at 4° C for 1 hr. At the end of incubation, 50 
pl of protein A-sepharose (50% v/v in PBS) were added to 
the solution and incubated at 4° C for 1 hr. The sepharose 
was then washed with the same buffer 3 times to remove the 
unbound antibodies and proteins. The protein-antibody 
complexes bound to the protein A-sepharose were solubilized 
by the SDS-PAGE sample buffer and analyzed by western blot 
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immunodetection using anti-VP4 or VP6 OAbs. As shown in 
Fig. 28, the VP6 protein was immunoprecipitated by anti-VP6 
MAbs. However, VP4 did not co-precipitate with VP6. The 
result indicated that VP4 and VP6 did not form a complex ~n 
v~vo. Similar results were obtained when the yeast two-
hybrid system (Clontech) was used to investigate the 
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FIG. 27. Summary of the construction of pAcUW51BTV13S3-M1. 
BTV-13 S3 cDNA·was cloned into the EcoR I site, and the 
expresslon of VP6 was controlled · by the p10 promoter. BTV-
13 M1 eDNA was cloned into the BarnH I site, and the 
expresslon of VP4 was controlled by the polyhedrin 
promoter. #: the site of BarnH I was destroyed by filling 
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FIG. 28. Analysis of the coexpresslon of VP4 and VP6 ln 
insect cells by western blot immunodetection. Insect cells 
infected with recombinant baculovirus carrylng BTV-13 S3 
and M1 eDNA were harvested, separated on SDS-PAGE, and 
transferred to nitrocellulose membranes as described ln 
CHAPTER III. (A) Immunodetection with anti-VP4 OAb #82 
(1:1000 dilution). (B) Immunodetection with anti-VP6 MAb 
(D34.5.7). Lane T: total cell lysate; LaneS: supernatant 
(soluble portion); Lane P: pellet (insoluble fraction). 
Duplicated samples were used for analysis. 
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FIG. 29. Irnrnunoprecipitation of insect cells coexpress1ng 
VP4 and VP6 proteins. The soluble fraction of the insect 
cell lysate (as described in Fig. 27) was 
immunoprecipitated with anti-VP6 MAbs (D34.5.7, D12.4.20, 
and H13.1). The immunoprecipitated complexes were 
separated on SDS-PAGE and transferred to nitrocellulose 
membranes. The membranes were immunodetected with anti-VP4 
OAb #82 (1:1000 dilution) or anti-BTV virion PAb #79 
(1:1000 dilution). The results indicated that VP4 and VP6 
proteins were not co-precipitated with anti-VP6 MAbs. Lane 
C: mock-infected cell lysate. 
APPENDIX D. 
RESULTS OBTAINED USING DIFFERENT REAGENTS FOR 




Results Obtained Using Different Reagents for 
Purifying VP4 from Insect (SF-9) Cells 
Lysis buffers (sonication) Solubilization buffers Solubility* Buffer for GTPbinding 
(1-5 scale) dialysis activity 
1% NP40, 150 mM MgCh, 200 mM MgCh, 10 mM OTT, 1 
50 mM Tris, pH 8. 
50 mM Tris, pH 8 
1% NP40, 1 mM EDT A. 1.5% N-Lauroyl Sarcosine, 5 PBS-ppt; No 
50mM Tris, pH 7.5 
50 mM Tris, pH 8 50mMTris (No RNA 
pH 8.8- ppt binding, 
either). 
Same as above 100 to 500 mM EDT A. 2 10 mM Tris, Yes (dot blot) 
50mM Tris, pH 8 pH 8- ppt 
Same as above 8 M urea (room temperature) 2.5 10 mM Tris, No 
pH 7.5-ppt 
Same as above 8 M urea, 10 or 50 mM DTT (at room 2.5 
temperature) 
Same as above 6 M Guanidine-HCI 3.5 10 mM Tris, No . 
pH 7.5-ppt 
1% NP40, 10 mM EDT A. 100 mM EDTA u 
50 mM HEPES, pH 7.3 
Same as above 1% Tw-20 in lysis buffer 0 
Same as above 1% Chaps in lysis buffer 0 
1% NP40, 1 OmM EDT A. 100 and 500 mM EDT A. pH 9 u 
50 mM Tris, pH 8.8 
Same as above 1% Tw-20 in PBS 0 
Same as above 1%DOC in PBS 1 No 
1% NP40, 0.2 M NaCI, 0 
10mM EDT A, 50mM Tris, pH 8 
0.01% NP40, 150 to 500 mM 0.001 to 0.1% NP40 0 Yes 
NaCI, or 150 mM MgCh (supernatant 
of lysis 
buffer) 
0.2 M NaC~ 10mM EDT A. VP4was 
50mM Tris, pH 8 detected in 
supernatant 
byOAb 
ppt: The protein precipitat~d during the dialysis. 
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